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Abstract
Protein kinase C delta (PKCδ) is an essential component of the intrinsic apoptotic
program. Following DNA damage, such as exposure to UV radiation, PKCδ is
cleaved in a caspase-dependent manner, generating a constitutively active catalytic
fragment (PKCδ-cat) which is necessary and sufficient for keratinocyte (KC)
apoptosis. We found that in addition to inducing apoptosis, expression of PKC-cat
caused a pronounced G2/M cell cycle arrest in both primary human KCs and
immortalized HaCaT cells. Consistent with a G2/M arrest, PKC-cat induced
phosphorylation of Cdk1 (Tyr15), a critical event in the G2/M checkpoint.
Treatment with the ATM/ATR inhibitor caffeine was unable to prevent PKCδ-cat
induced G2/M arrest, suggesting that PKCδ-cat is functioning downstream of
ATM/ATR in the G2/M checkpoint. To better understand the role of PKC and
PKCδ-cat in the cell cycle response to DNA damage, we exposed wild type and
PKC null MEFs to UV radiation. Wild type MEFs underwent a pronounced G2/M
arrest, Cdk1 phosphorylation, and induction of apoptosis following UV exposure,
while PKC null MEFs were resistant to these effects. Expression of PKCδ-GFP, but
not caspase-resistant or kinase inactive PKCδ, was able to restore G2/M checkpoint
integrity in PKCδ null MEFs. The function of PKC in the DNA damage-induced
G2/M cell cycle checkpoint may be a critical component of its tumor suppressor
function.

xvi

In light of recent reports suggesting the importance of nuclear localized PKCδ in the
apoptotic response, we examined changes in PKCδ sub-cellular localization
following exposure to UV radiation.

Using a PKCδ-GFP fusion protein we

determined that nuclear PKCδ was present after UV exposure, and that it formed
foci coinciding with regions of intense DAPI staining, suggesting localization to
condensed chromatin. We have previously shown that expression of the PKCδ
catalytic fragment induced phosphorylation of Histone H3 (Ser10), an important
event for mitotic chromatin condensation. Interestingly, PKCδ-cat induction of
P~H3(S10) was not prevented by inhibition of the mitotic H3 kinase Aurora B, and
was induced throughout all phases of the cell cycle, supporting the idea that this
event is distinct from the P~H3(S10) induction during mitosis.

In vitro

phosphorylation studies using recombinant proteins demonstrated that PKCδ-cat is
capable of directly phosphorylating H3 on Ser10 raising the possibility that PKCδ
may function as a Histone H3 kinase in the cell. Using confocal microscopy we
found that UV-induced PKCδ-GFP foci co-localized with regions of positive
P~H3(S10) staining. To avoid any artifacts associated with over-expression of the
PKCδ-GFP fusion protein, we confirmed the formation of endogenous PKCδ foci
after UV radiation in normal keratinocytes. This novel chromatin modifying activity
of PKCδ may be an important component of its tumor suppressor function for UVinduced skin cancers in the human epidermis.

xvii
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Chapter One
I. Introduction

1.1 Epidermal Biology and Cancer
1.1.1 Epidermal Structure and Function

The epidermis is the outermost layer of the skin and the largest organ by weight in the
human body. The skin performs many critical functions including providing a protective
barrier against infection and the environment as well as maintaining a waterproof layer
that prevents loss of water from the human body. The skin is composed of two major
layers, the dermis and the epidermis. The dermis is a largely acellular region, consisting
primarily of extra-cellular matrix (ECM) proteins, dermal fibroblasts, blood vessels, hair
follicles, and sebaceous glands. Dermal fibroblasts secrete the ECM components and
other factors that nourish and support the epidermis. The epidermis represents the
outermost layer of the skin, and largely consists of the structural cell of the skin, the
keratinocyte. Also residing within the epidermis are pigment producing melanocytes and
antigen-presenting Langerhaan cells.

Separating the epidermis and dermis and providing a critical anchoring site for basal
keratinocytes is the basement membrane. This membrane is composed of ECM proteins
and cell membrane receptors including α6β4 integrins and laminin-5 and prevents
invasion of keratinocytes and melanocytes into the dermis (Niessen et al., 1994).
Importantly, during carcinogenesis, matrix-metalloproteinases secreted by neoplastic
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keratinocytes or melanocytes can degrade the basement membrane, allowing invasion of
the transformed cells into the dermis and eventually the bloodstream.

The epidermis is a self-renewing tissue, ensuring efficient wound healing post-injury and
constant replenishment of the tissue during normal homeostasis. Residing in the basal
layer of the epidermis, proliferating keratinocytes detach from the basement membrane,
undergo irreversible growth arrest, and begin a sequential differentiation program that
ultimately results in cell death and cornification. The epidermis consists of several
distinct layers of keratinocytes at various stages of differentiation. These layers include
the basal layer, which contains self-renewing undifferentiated keratinocytes, the
intermediate spinous and granular layers, and finally the outermost cornified layer which
contains dead keratinocytes and the barrier proteins of the skin, including loricrin,
involucrin, and filaggrin (Dale and Holbrook, 1987; Presland and Dale, 2000). In direct
relation to the increasing level of differentiation during progression from basal to apical
regions of the epidermis is a calcium gradient (Menon et al., 1985). The increasing levels
of calcium in the suprabasal layer are critical for epidermal barrier function and
keratinocyte differentiation through the activation of the classical protein kinase C
isoform, PKCα (Elias et al., 1998; Jaken and Yuspa, 1988; Jerome-Morais et al., 2009).
Evidence for the critical role of calcium in keratinocyte differentiation is further bolstered
by the common use of elevated Ca²+ to induce the differentiation of cultured
keratinocytes (Hennings et al., 1980).
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During the keratinocyte differentiation process there is a progressive downregulation of
cell cycle and proliferation genes such as cyclin D1 and upregulation of differentiation
genes such as keratin 1 and 10, desmoglein 1 and ultimately, barrier proteins such as
loricrin and profilaggrin. It is believed that the coordinated array of gene activation and
repression during differentiation is controlled by epigenetic regulators such as DNMT1,
DNMT3a, and DNMT3b as well as the histone demethylase, JMJD3 (Sen et al., 2010;
Sen et al., 2008). In addition, the classical protein kinase C isoform, PKCα, is critical for
activating the initial growth arrest following detachment of the differentiating
keratinocyte from the basement membrane (Jerome-Morais et al., 2009). PKCδ and η
have also been implicated in the keratinocyte differentiation program (Adhikary et al.,
2010; Kamioka et al., 2010; Szegedi et al., 2009; Cabodi et al., 2000). PKCδ, for
example, is critical for the proper epidermal differentiation associated upregulation of
involucrin in human keratinocytes (Deucher et al., 2002).

1.1.2 Epidermal Tumorigenesis and Cancer

According to the National Cancer Institute (NCI), epidermal tumors are by far the most
commonly diagnosed malignancies in the United States of America with over one million
new cases diagnosed each year. There are several types of skin cancer that vary in clinical
prognosis depending on the type of cell giving rise to the tumor, as well as the stage of
cancer progression at the time of diagnosis. It has been understood for some time that
there was a relationship between sun exposure and skin cancers in humans, early work
proved the direct link between ultraviolet radiation and skin carcinogenesis in mice in the
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1960’s (Epstein and Epstein, 1963; Fisher and Kripke, 2002; Cleaver and Crowley,
2002).
1.1.3 Ultraviolet Radiation and Carcinogenesis
The sun emits a wide range of radiation on the electromagnetic spectrum. This includes
high-energy wavelengths such as ionizing radiation as well as lower energy wavelengths
including the visual spectrum and infrared radiation. Included in the spectrum of light
emitted by the sun is ultraviolet (UV) radiation. UV radiation encompasses 100-400 nm
wavelengths and is further divided into UV A, B, and C wavelengths. UVC is the highest
energy, lowest wavelength form of UV radiation and is commonly used in germicidal
lights for sterilization. UVC is emitted from the sun, but does not reach the surface of the
Earth because it is absorbed by the outer atmosphere. In contrast, UVA and B are also
emitted from the sun, but are less efficiently absorbed by the atmosphere and reach the
Earth’s surface at appreciable levels. Notably, the thinning of the ozone layer correlates
with increased levels of UVA and UVB radiation reaching the surface of the Earth. This
has lead to a significant increase in skin cancer incidence in areas such as Australia where
the thinning of the ozone layer is more pronounced than other regions (de Gruijl, 1999).

UVB, and possibly to a lesser extent UVA radiation, is highly carcinogenic in humans
(de Gruijl et al., 1993). Exposure of DNA to UVB radiation generates bulky DNA
adducts, including thymine dimers and 6-4 photoproducts, as well as oxidative damage to
the DNA represented by formation of 8-oxo-2'-deoxyguanosine (Hemminki, 1993). The
presence of these adducts on a DNA molecule distorts the double helix and can cause
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errors in DNA replication and thus result in potentially carcinogenic mutations being
incorporated into the genome of damaged keratinocytes or melanocytes (Sinha and
Hader, 2002). Because the damage caused by UV radiation is sequence specific, specific
UV signature mutations have been characterized, the most common being CC to TT and
C to T mutations, with GC to AT mutations also commonly detected (Miller, 1985; Brash
et al., 1987). Mutations that follow these patterns have been detected throughout critical
cancer related genes such p53, indicating why p53 function is altered in many cases of
NMSC (Brash et al., 1991).

UVA has long been considered to be less harmful than the higher energy forms of UV
radiation, however recent evidence has revealed that UVA can also have a carcinogenic
effect on the skin, although the mechanism is less understood. The direct mutagenic
effect of UV radiation exposure on DNA molecules underscores the vital role of cell
cycle checkpoints in recognizing damage, preserving genomic integrity. These
checkpoints will be discussed in depth later in this document.

1.1.4 The Epidermal Keratinocyte

Keratinocytes are the structural cell of the epidermis and are the most common cell type
in the skin. In the basal layer of the epidermis, self-renewing keratinocytes divide
asymmetrically, allowing for maintenance of the proliferative compartment while giving
rise to post-mitotic keratinocytes that make up the supra-basal layers (Lechler and Fuchs,
2005). Supra-basal keratinocytes undergo a sustained growth arrest and differentiation
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program that ultimately results in cell death and cornification. This differentiation process
results in expression of key proteins such as loricrin, filaggrin, and involucrin, which
provide the skin with its barrier function.

Disruption of this growth arrest and differentiation process can results in keratinocyte
neoplasias and non-melanoma skin cancers (NMSC). NMSCs includes both basal and
squamous cell carcinomas, which together account for over 1 million new cases
diagnosed within the United States each year. This makes non-melanoma skin cancer the
most common form of cancer by far. Generally, these cancers are associated with a
relatively low rate lethality with approximately 1000 deaths each year being attributed to
metastatic growth of NMSCs. Despite this, preventing their formation using prophylactic
treatments with sunscreens or lotions would decrease the significant morbidity associated
with the treatment and removal of these tumors.

1.1.5 The Epidermal Melanocyte

Melanocytes originate from the neural crest during development. In the epidermis,
melanocytes are responsible for producing skin pigmentation through generation of
melanins. Once produced, these pigmented compounds are passed to keratinocytes where
they absorb UV radiation, thus protecting epidermal cells from the carcinogenic effects of
UV radiation exposure.
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The most deadly skin cancer, malignant melanoma, arises from epidermal melanocytes.
According to the NCI, approximately 70,000 new cases of cutaneous melanoma are
diagnosed within the United States each year. While melanoma patients diagnosed with
pre-metastatic disease have a favorable 5 year survival rate, those diagnosed with
advanced metastatic disease have a 5 year survival rate of only 15.8% (Altekruse SF et
al., 2009). This is because melanomas often display significant resistance to standard
treatments such as chemotherapy and radiation. They also present with a high rate of
metastasis to vital organs such as the brain and liver, making this form of skin cancer
highly lethal.
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1.2 Cell Cycle and Proliferation
1.2.1 Cell Cycle Overview

Multi-cellular eukaryotes, such as humans and mice, undergo a tightly controlled cell
cycle in which the entire genome and cellular contents are replicated and equal halves are
divided into two daughter cells (Figure 1). While it has been understood for decades that
cells undergo a mitotic cell division process, the idea of a cell cycle in which the cells
commit to DNA replication and division is more recent (Smith and Martin, 1973). Proper
control of the cell cycle is critical in preventing aberrant proliferation, as well as ensuring
that genomic mutations are not propagated to daughter cells. The majority of
differentiated cells in the body are in a state of senescence or quiescence, depending on
the tissue and cell type. These cells have for the large part, permanently exited the cell
cycle and undergone terminal differentiation, allowing them to support the organ and
tissue architecture in which they exist.

Despite the predominance of post-mitotic cells in the human body, proliferating cell
populations make up a significant component of self-renewing tissues. For example,
proliferating basal layer keratinocytes are critical for the replenishment of the suprabasal
layers of the epidermis and are absolutely required for epidermal integrity (Regnier et al.,
1986). Similarly, crypt cells in the small intestine migrate away from the basal region of
the crypt and undergo terminal differentiation to become one of a number of cell types
critical for barrier function and nutrient absorption in the colon (Humphries and Wright,
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Figure 1 – Overview of the Eukaryotic Cell Cycle. The eukaryotic cell cycle is
tightly controlled. Progression through several “checkpoints” at key
transitions in the cell cycle requires the coordinated
activation/inhibition of various cyclin-dependent kinase activity. These
kinases are tightly controlled, and can only be activated upon binding
of cyclin proteins, whose expression is strictly limited to specific cell
cycle phases, ensuring that Cdk activity is only activated in the proper
cell cycle compartment.

10
2008). The signal responsible for driving this growth arrest and differentiation program is
likely unique to each individual tissue and cell type.
The eukaryotic cell cycle can be broken down into several stages. These stages are
known as G1, S, G2, and finally mitosis (M). There is an additional cell cycle stage G0,
in which the cell has permanently (senescence), or reversibly (quiescence) exited the cell
cycle. The G1, or gap 1 phase of the cell cycle is tightly regulated by factors such as
nutrient availability, cell-cell contact, and other extrinsic and intrinsic criterion that must
be satisfied before the cell commits to undergoing a cell cycle. Once a cell has proceeded
through the restriction checkpoint in early G1 phase, it has committed to division and
now contains only intrinsic barriers to checkpoint progression. Importantly, the presence
of mitogenic factors is critical for passage through the restriction point and the
commitment to cell division. When a cell has determined that there are sufficient biomaterials available, the cell passes through the G1/S boundary and begins S phase.

The cell cycle stage known as S phase encompasses the period of genomic replication
that occurs before a cell can undergo division. During S phase, the cell precisely
replicates each and every one of its chromosomes. In this way the cell exits S phase
having completely replicated the genome only once and is prepared to pass through the
G2 phase into mitosis.

During G2 phase, a gap phase significantly shorter than G1, the cell prepares to enter
mitosis. Once all required mitotic proteins are synthesized, the cell passes through G2
into mitosis where it undergoes chromatin condensation, metaphase alignment and
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segregation of the chromatin into two equal halves. Once proper chromosome segregation
has taken place, the cell completes the division process separating the two daughter cells
which are now in a G0/G1 cell cycle stage. At this stage, one full cell cycle is completed.

1.2.2 Cell Cycle Checkpoints: Critical Guardians of the Genome

As previously mentioned, cell cycle progression is a tightly regulated process.
Throughout the cell cycle, specific Cyclin-dependent kinases (Cdks) are required for cell
cycle progression (Figure 1). These Cdks are dependent upon binding of cyclin proteins
for their kinase activity and are tightly regulated by phosphorylation and cytoplasmic
sequestration by 14-3-3 chaperone proteins. Thus, while the Cdk proteins are expressed
fairly evenly across all phases of the cell cycle, their activity is constrained to specific
stages by the regulation of cyclin expression and binding. The first cyclin was identified
as a protein which was rapidly degraded upon the onset of cell division (Evans et al.,
1983). The importance of cyclins for cell cycle progression was realized when it was
described that their injection into Xenopus oocytes induced meosis or mitosis (Swenson
et al., 1986).

The critical importance of proper Cdk/cyclin complex regulation is revealed in the fact
that many cancers overexpress one or multiple Cdks and cyclins. For example, cyclin D
and Cdk4 are two commonly overexpressed oncogenes in many cancer types (Kim and
Diehl, 2009; An et al., 1999). The balance between cell cycle arrest and progression is
struck by the degree to which Cdk/cyclin complexes are activated or inhibited and this

12
balance is governed by cell cycle checkpoints. Cell cycle checkpoints are coordinated
signal transduction cascades that respond to a wide variety of stimuli and exert a negative
force on cell cycle progression. Checkpoint activation halts the cell cycle, allowing time
for the cell to resolve the checkpoint stimuli before checkpoint activation is alleviated,
and cell cycle progression can resume.

The misregulation of cellular proliferation can give rise to hyperproliferative disorders
and ultimately, malignant cancers. It is therefore critical that mechanisms are in place to
prevent cell cycle misregulation from occurring. As a result, higher eukaryotes have
developed multiple cell cycle checkpoints that are able to halt cell cycle progression in
response to a wide range of stimuli, including but not limited to nutrient deprivation,
DNA damage, or unattached mitotic spindles. Loss of checkpoint function is known to be
a causative effect in many types of cancer. For example, over 50% of all tumors have
mutated p53 function (Gasco et al., 2002). Similarly, many cancers have mutations in
some component of the Rb signaling pathway resulting in premature G1/S phase
transition (Nevins, 2001). Finally, many familial cancer syndromes involve mutations to
critical cell cycle and DNA repair genes, including Li-Fraumeni Syndrome (p53),
Fanconi’s anemia (FANC genes), ataxia telangiectasia (ATM), xerodermum pigmentosa
(XP genes), Nijmegan Breakage Syndrome (Nbs1), Cockayne (ERCC) syndrome and
many others (Li and Fraumeni, Jr., 1969; Strathdee et al., 1992; Savitsky et al., 1995b;
Savitsky et al., 1995a; Cleaver et al., 2009; Weemaes et al., 1981; Tauchi et al., 1999;
Weeda et al., 1990). Many of the genes involved in these disorders will be discussed
more extensively in later sections.
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1.2.3 Intrinsic Versus Extrinsic Checkpoints

Cell cycle checkpoints can be sorted into two encompassing categories, namely intrinsic
and extrinsic checkpoints. Extrinsic checkpoints can only be satisfied by external stimuli.
For example, mitogenic growth factors must be present and bound to their corresponding
receptors to initiate a signal transduction cascade that drives a cell through said
checkpoint. An example of an extrinsic checkpoint in eukaryotic cells is the restriction
point in G1, in which growth factor stimulation drives a cell to commit to the cell cycle
(Pardee, 1974). In contrast, intrinsic cell cycle checkpoints are satisfied by meeting
requirements that arise within the cell itself. These checkpoints include the G1/S and
G2/M phase cell cycle checkpoints.

1.2.4 The G1/S Phase Checkpoint

The G1/S checkpoint is a critical guardian of the genome and prevents premature
initiation of genomic replication. The main effectors of the G1/S phase checkpoint
include such vital tumor suppressors as p53 and the retinoblastoma pocket protein family.
The critical effector step in the G1/S checkpoint is the binding of Rb family proteins to
the transcription factor E2F1. This binding prevents the transcriptional activation of E2F1
target genes that are critical for initiating S phase and DNA replication. The mechanism
by which Rb inhibits E2F1 dependent transcription likely involves the recruitment of corepressor complexes containing among other things histone methyltransferases and deacetylases (Nielsen et al., 2001; Petrie et al., 2008; Wang et al., 2002).
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The Rb protein was first identified as the gene mutated in familial retinoblastoma, and the
genetic studies of these cancers led to the two-hit paradigm of carcinogenesis (Knudson,
Jr., 1971). The Rb protein exists in several phosphorylation states within a cell depending
on the cell cycle status (Buchkovich et al., 1989; Chen et al., 1989). Interestingly,
senescent and quiescent G0 cells contain a completely unphosphorylated Rb, suggesting
complete inactivation of Cdk4/6 and Cdk2 activity (Futreal and Barrett, 1991). Cells in
early- to mid-G1 contain primarily hypo-phosphorylated Rb. This hypo-phosphorylation
of Rb is catalyzed by Cdk4/cyclin D although whether this enhances or inhibits Rb
activity remains controversial. As cells progress through late G1 phase, gradual activation
of Cdk2/cyclin E complexes leads to the hyperphosphorylation of Rb. This
hyperphosphorylation of Rb inhibits Rb activity, and leads to dissociation of the
RB/E2F1 complex (Harbour et al., 1999). The release of E2F1 from Rb results in the
E2F1 dependent transcription of critical S phase genes like DNA polymerase and PCNA
(DeGregori et al., 1995).

In addition to regulation of cell cycle progression by inhibiting transcription of E2F target
genes, the Cdk/cyclin complexes are themselves subjected to tight regulation by the
binding of Cdk inhibitor proteins (CKI). These proteins include p21, p16INK4A, and
p27. CKIs are inhibitors of Cdk/cyclin complexes and suppress kinase activity to these
complexes upon binding. Following DNA damage, p21 is transcribed in a largely p53dependent manner and induces G1/S phase arrest by inhibiting the activity of both Cdk4
and Cdk2 (El Deiry et al., 1993; Harper et al., 1993; He et al., 2005a). Similarly to p21,
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the CKI p16 was first identified as a 16 kDa protein that bound to and inhibited Cdk4 in
response to SV40 or oncogenic Ras transformation in fibroblasts (Serrano et al., 1993;
Serrano et al., 1997). Interestingly, the p16INK4a gene locus overlaps with another tumor
suppressor, p19ARF, which stabilizes p53 by limiting the ability of MDM2 to induce p53
degradation (Quelle et al., 1997; Serrano et al., 1996; Kamijo et al., 1997; Pomerantz et
al., 1998). p27kip1 is an additional Cdk inhibitor that appears to have specificity for the
inhibition of Cdk2/cyclin E complexes (Polyak et al., 1994).

Adding a further layer of complexity to the regulation of G1/S cell cycle progression is
the presence of Cdk activating kinases (CAKs) which phosphorylate the T-loop of Cdk1
and 2 (Kamijo et al., 1997; Fesquet et al., 1993). The precise identity of the CAK acting
at various cell cycle stages remains controversial, however it is believed that Cdk7/cyclin
H may function as a CAK during both G1/S and G2/M cell cycle progression (Jeffrey et
al., 1995; Matsuoka et al., 1994; Fisher and Morgan, 1994).

1.2.5 Intra-S-Phase Checkpoints and the Regulation of DNA Replication

It is well known that the treatment of cells actively replicating DNA in S phase with
hydroxyurea or DNA damage causes a decrease in the rate of nascent DNA synthesis
(Harper and Elledge, 1998). This suggests that a system is in place to monitor the genome
for damage, even following commitment to the cell cycle and DNA replication. Indeed,
much work has been done to characterize the so-called intra-S phase checkpoints. This
work has revealed the critical importance of Mec1 and Rad53 in decreasing late-origin
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firing during DNA replication after damage is detected (Grallert and Boye, 2008; Tercero
and Diffley, 2001). This results in an overall decreased rate of DNA synthesis, allowing
time for the repair of DNA damage.

1.2.6 G2/M Cell Cycle Regulation

Similar to the series of checkpoints in place at the G1/S phase boundary, progression into
mitosis from the G2 phase is a tightly regulated process. The G2/M checkpoint has
evolved to prevent cells from prematurely entering mitosis, or from entering mitosis in
the presence of DNA damage. Prior to mitotic entry cells must first satisfy a series of
requirements before entry into mitosis is permitted, the ultimate requirement being the
activation of the cyclin dependent kinase, Cdk1.

1.2.7 Cdk1 Activity and Inhibition during G2 and Mitosis

Cdk1 was first identified as the protein cdc2, which was identified as a critical factor for
mitotic entry in Schizosaccharomyces pombe (Nurse and Thuriaux, 1980). Cdc2 was
subsequently identified in higher eukaryotes as a component of the mitosis promoting
factor in Xenopus laevis (Dunphy et al., 1988). Additional studies identified cdc2 as a
cyclin dependent kinase, capable of binding both cyclin A and B (Dunphy et al., 1988;
Draetta et al., 1989). Several conditions must be met for Cdk1 activation to occur. The
first is the synthesis and binding of cyclin B to Cdk1. As cyclin B protein levels are
regulated by cell cycle stage, this ensures that Cdk1 activation can only occur in late S
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and G2 phases of the cell cycle. In addition to cyclin B binding, Cdk1 is also
phosphorylated on its T-loop by Cdk7, an event that is important for cyclin binding and
subsequent Cdk1 activation (Draetta and Beach, 1989).

1.2.8 The G2/M DNA Damage Checkpoint

Opposing the activation of Cdk1/cyclin B and entry into mitosis is a signal transduction
cascade that prevents the premature or inappropriate entry into mitosis (Figure 2). This
pathway culminates with the inhibitory phosphorylation of Cdk1 on Thr 14 and Tyr 15
and is known as the G2/M checkpoint. The G2/M checkpoint ensures that cells do not
enter mitosis in the presence of DNA damage, and thus preserves genomic integrity.
Conversely, the G2/M DNA damage checkpoint is a target of cancer therapy, as the
inhibition of this checkpoint in the presence of DNA damage is known to induce cancer
cell death.
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Figure 2–The G2/M DNA Damage Checkpoint. DNA damage in G2 activates a
signal transduction cascade that culminates in the inhibition of
Cdk1/cyclin B complex, which is required for cells to enter into the
prophase of mitosis. Some of the key components of the G2/M
checkpoint are displayed above. Proteins and events that promote
G2/M checkpoint activation are displayed in red. Proteins that promote
mitotic entry are displayed in green.
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1.2.9 The Cdk1 Kinases, Wee1 and Myt1

During progression through the G2-phase, and during conditions in which the G2/M
checkpoint is active, Cdk1 is phosphorylated on Tyr15 and Thr14. These phosphorylation
events are catalyzed by the kinases Wee1 and Myt1 (Parker et al., 1995; Parker and
Piwnica-Worms, 1992; Piwnica-Worms et al., 1991; Mueller et al., 1995; Booher et al.,
1997). This phosphorylation event is critical for the inhibition of Cdk1 activity that
prevents cells from inappropriately entering mitosis (Rhind et al., 1997). The expression
and activity of Wee1 and Myt1 increase as cells pass through S and into the G2 phase
until entry into mitosis, when Wee1 is degraded as a result of Plk1 mediated
hyperphosphorylation (Watanabe et al., 1995; van Vugt et al., 2004). As the inhibitory
phosphorylation of Cdk1 is the ultimate outcome of G2/M checkpoint signaling, it is not
surprising that the checkpoint kinase, Chk1, can phosphorylate and activate Wee1
directly (Raleigh and O'Connell, 2000).

1.2.10 Cdc25 Family Phosphatases

During the entry into prophase, Cdk1 becomes sequentially dephosphorylated on Thr 14
and Tyr 15 (Borgne and Meijer, 1996). Cdc25 phosphatases are absolutely required for
this dephosphorylation event to take place. The Cdc25 phosphatase family contains three
isoforms, A, B, and C that differ in pattern of expression across the cell cycle, as well as
their mode of regulation. These phosphatases are responsible for removing inhibitory
phosphorylation marks on Cdk kinases, and thus are positive regulators of the cell cycle
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(Gautier et al., 1991; Lee et al., 1992; Dunphy and Kumagai, 1991). Due to their positive
regulation of Cdk activity, Cdc25 family phosphatases can be classified as putative
oncogenes (Galaktionov et al., 1995). Indeed, Cdc25 A and B are commonly
overexpressed and associated with poor prognosis in many cancer types, including
colorectal, gastric, head and neck, and non-small cell lung cancers (Gasparotto et al.,
1997; Kudo et al., 1997; Wu et al., 1998; Takemasa et al., 2000; Kristjansdottir and
Rudolph, 2004).

As described in section 1.2.13, Cdc25 phosphatases are negatively regulated by Chk1/2
phosphorylation. Chk1/2 phosphorylation of Cdc25 leads to cytoplasmic sequestration
and inhibition of phosphatase activity via binding to 14-3-3 chaperone proteins (Conklin
et al., 1995; Peng et al., 1997; Dalal et al., 1999). Cdc25A is rapidly degraded during
checkpoint activation in response to phosphorylation by Chk1 (Mailand et al., 2000;
Molinari, 2000). It is now understood that the ubiquitin ligase, SCF binds to
phosphorylated Cdc25A following DNA damage, and promotes ubiquitination
degradation of Cdc25A (Donzelli et al., 2002). In contrast, Cdc25C is primarily regulated
by hyperphosphorylation, and is not detectably degraded following checkpoint activation.

Complex genetic studies in mice have demonstrated that the three Cdc25 isoforms are at
least somewhat redundant in their function. The loss of Cdc25 B or C individually, or
Cdc25B and C together demonstrated no detectable phenotype, suggesting that Cdc25A
is able to compensate for loss of B and C (Chen et al., 2001). In contrast, the Cdc25A-/mutation was embryonic lethal. Furthermore, conditional knockout of Cdc25A in adult
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mice lacking Cdc25B and C resulted in severe intestinal hypoplasia, and rapid death due
to loss of intestinal crypts (Lee et al., 2009). This indicates that Cdc25A can complement
loss of Cdc25B or C, but that Cdc25A has important and necessary roles during early
embryogenesis and normal tissue homeostasis. It is therefore likely that the aberrant
expression of even one Cdc25 isoform would be sufficient to override cell cycle
checkpoint activation in response to DNA damage.

1.2.11 The ATM and ATR Checkpoint Kinases

Several kinases are activated downstream of the recognition of DNA damage. Ataxia
telangiectasia mutated kinase (ATM) was discovered based on its mutation in the
congenital ataxia telangiectasia (A-T) disease (Savitsky et al., 1995b; Savitsky et al.,
1995a). A-T is a rare, congenital disorder that is associated with severe hypersensitivity
to ionizing radiation. This sensitivity occurs due to defects in the ATM protein which
result in impaired checkpoint signaling following ionizing radiation exposure. This
defective signaling results in genomic instability and increased cancer incidence. Ataxia
telangiectasia and Rad3 related kinase (ATR) is another DNA damage-activated kinase
that is critical for proper checkpoint signaling following UV-radiation exposure (HallJackson et al., 1999; Cimprich et al., 1996). ATR binds to sites of UV-damaged DNA via
interaction with ATR-interacting protein ATRIP (Cortez et al., 2001). ATR binding to
ATRIP results in ATR activation and propagation of a signal transduction cascade that
promotes cell cycle arrest, and DNA repair.
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1.2.12 Differential Activation of ATM and ATR

Depending on the type of DNA present in the cell, the response towards that damage can
vary greatly. This includes the activation of different repair mechanisms, as well as the
coordination of different cell cycle regulators. This can be seen by the differential
activation of ATM and the related kinase, ATR (Helt et al., 2005). Following double
stranded break formation, such as occurs during ionizing radiation exposure, ATM is
activated, and exerts a negative force on the cell cycle by phosphorylating Chk2 on Thr
68 and p53 on Ser 15 (Matsuoka et al., 2000; Canman et al., 1998). In contrast, ATR
responds to UV-induced DNA adducts and replication fork collapse by phosphorylating
and activating Chk1 on Ser 345 and p53 on Ser 15 (Zhao and Piwnica-Worms, 2001;
Tibbetts et al., 1999). While activation of both Chk 1 and 2 have the effect of halting the
cell cycle, the differential activation of ATM and ATR allows the cell to detect a wide
array of genotoxic events, and respond accordingly. Interestingly, caffeine, a
radiosensitizing agent with known anti-cancer properties is an inhibitor of both ATM and
ATR kinase activity (Sarkaria et al., 1999) For example, treatment with caffeine
sensitizes keratinocytes to apoptosis following UV exposure by inhibiting the ATR-Chk1
signaling axis (Heffernan et al., 2009; Lu et al., 2008; Lu et al., 2004; Lu et al., 2002;
Conney et al., 2008; Conney et al., 2007).

1.2.13 The Checkpoint Kinases, Chk1 and Chk2
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Immediately downstream of ATM and ATR kinases in the DNA damage cell cycle
checkpoints are the checkpoint kinases Chk1 and Chk2. Upon activation, both kinases
phosphorylate and inactivate the Cdc25 family of phosphatases and thus indirectly inhibit
Cdk/cyclin complex activity. Which Chk kinase is activated depends on the upstream
checkpoint kinases activated, as well as the cell cycle stage in which the damage was
detected. Chk2 is primarily activated by ATM phosphorylation on Thr68, and is primarily
activated during G1 and S phase checkpoint responses. Once activated by ATM, Chk2
inhibits Cdc25C by direct phosphorylation on Ser 216, resulting in cell cycle arrest
(Matsuoka et al., 1998). In addition to inhibiting Cdc25 activity, Chk2 also
phosphorylates and activates p53 during the DNA damage response (Hirao et al., 2000).

Chk1 is activated primarily by phosphorylation on Ser345, and is critically important for
the G2/M cell cycle checkpoint. Chk1 is a critical downstream mediator of ATM
checkpoint signaling, as the ectopic expression of Chk1 can restore G2/M checkpoint
integrity in ataxia-telangiectasia cells, which are known to have impaired ATM function
(Chen et al., 1999b). The critical importance of these genes is revealed by the finding that
Chk1 null mice die at E2.5 from p53-independent apoptosis. Furthermore, it was
demonstrated that Chk1 was essential for G2/M checkpoint activation following ionizing
radiation in murine ES cell lines. Chk1 is a bona fide tumor suppressor, as Chk1
heterozygous null mice have an increased incidence of mammary tumor formation in the
presence of WNT-1 ligand expression (Liu et al., 2000).
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1.2.14 Mitosis and Regulation of Mitotic Progression

It is now well established that Cdk1/cyclin B activity is critical for mitotic entry. The cell
cycle phase known as mitosis consists of at least 6 distinct stages, prophase,
prometaphase, metaphase, anaphase, telophase, and finally cytokinesis. In addition to the
extensive regulation of mitotic entry, there are highly complex regulatory pathways
within mitosis that ensure the equal distribution of chromosomes to each newly forming
daughter cell.

The first stage of mitosis is the prophase. During prophase, Aurora B kinase becomes
active and phosphorylates histone H3 on Ser10 and Ser28 (Giet and Glover, 2001; Goto
et al., 2002). This phosphorylation is thought to promote mitotic chromatin condensation
through the recruitment of condensin proteins (Schmiesing et al., 2000). Notably,
however, yeast possessing an H3(S10A) mutation still efficiently condense chromatin
during prophase, and are able to complete mitosis comparably to their wild type
counterparts (Hsu et al., 2000; Prigent and Dimitrov, 2003). While this may call into
question the direct requirement for H3(S10) phosphorylation during mitotic chromatin
condensation, this discrepancy may reflect differences in mitotic regulation between
yeast and higher eukaryotes. Simultaneous to the condensation of chromatin during
prophase, is the reversible breakdown of the nuclear envelope which is associated with
depolymerization of the nuclear lamina (Gerace and Blobel, 1980). Dissociation of the
nuclear lamina occurs following phosphorylation of lamin B envelope proteins by
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Cdk1/cyclin B (Peter et al., 1990; Courvalin et al., 1992). Notably, this reversible
depolymerization differs from the irreversible dissociation that occurs during apoptosis.

The process of chromatin condensation and nuclear envelope breakdown occurs
throughout prophase and prometaphase. Another key process that begins during
prometaphase is the generation of bipolar mitotic spindles from the centrosomes.
Centrosomes contain γ-tubulin and provide the seeding site for α- and β-tubulin
polymerization in the formation of the mitotic spindle apparatus. As spindle formation
occurs, the leading edge of the spindle connects to the kinetochore of one of a pair of
sister chromatids. It is critically important that during spindle attachment, each pair of
sister chromatids are attached to a spindle associated with opposing centrosomes. This
ensures equal chromosomal segregation during the later stages of mitosis. The correct
bipolar attachment of spindles to each kinetochore is a key factor monitored by the
spindle-attachment checkpoint during the next stage of mitosis, metaphase. The
importance of spindle assembly and attachment to the successful completion of mitosis is
evident in the success of microtubule poisons such as paclitaxel and docetaxel as anticancer agents. These compounds disrupt microtubule dynamics by preventing αβ-tubulin
depolymerization and thus prevent proper kinetochore attachment and chromosomal
segregation (Schiff and Horwitz, 1980).
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1.2.15 Metaphase and the Spindle Assembly Checkpoint

As nuclear envelope breakdown and chromatin condensation completes, the kinetochores
of each chromosome associate in a bipolar manner with the mitotic spindle apparatus. As
this association occurs, the chromatin migrates to the metaphase plate, which is
perpendicular to the axis between the two centrosomes. Cells maintain a metaphase arrest
until each kinetochore is attached to a mitotic spindle in what is known as the spindle
assembly checkpoint (Wells and Murray, 1996; Wells, 1996). Amazingly, the presence of
even one unattached kinetochore is sufficient to maintain activation of the spindle
assembly checkpoint and prevent the cell from progressing into anaphase. The signal
emanated from unattached kinetochores is thought to arise from binding to Mad2 protein
(Chen et al., 1996). This binding efficiently prevents activation of the Anaphase
Promoting Complex, whose activity is critical for anaphase progression.

In order for the cell to overcome a metaphase arrest, and proceed into anaphase, the
activity of Cdk1/cyclin B must first be inhibited (Lorca et al., 1992). Once conditions for
satisfying the spindle assembly checkpoint have been met, Cdc20 accumulates, binds to
and activates the Anaphase Promoting Complex/Cyclosome (APC) (Fang et al., 1998b;
Fang et al., 1998a). The APC/C is a ubiquitin ligase, that targets many mitotic regulators,
including cyclin B for proteasomal degradation (King et al., 1995).

Another key substrate of APC/C is securin protein. While unattached kinetochores are
present in the mitotic cell, securin binds to and inactivates separase proteins
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(Waizenegger et al., 2002). This inactivation prevents separase from cleaving the cohesin
protein complexes that maintain sister chromatid attachment. Thus APC/C promotes
anaphase entry through promoting degradation of multiple proteins, including cyclin B
and securin (Leismann and Lehner, 2003).

1.2.16 Chromatin Segregation and Cytokinesis

Once all kinetochores are properly attached to the bipolar mitotic spindle, the spindle
assembly checkpoint is satisfied, and the cell enters anaphase. The onset of anaphase
occurs following degradation of the cohesin complexes that connect sister chromosomes
and prevent their separation (Michaelis et al., 1997). Cohesin removal allows the
centrosomes to pull the sister chromosomes in opposite directions, ensuring equal copies
of each chromosome will be present in both daughter cells. As the chromatin is drawn
towards the centrosomes, the cell progresses through anaphase and telophase into the
final phase of mitosis, cytokinesis, during which the process of cell division is completed.

Cytokinesis is the physical process of cell division, and can occur only upon completion
of chromosomal segregation. Once segregation is completed, a contractile ring containing
actin and myosin filaments forms between the two newly forming daughter cells and
begins to form what is known as the cleavage furrow (Sanger, 1975). This contractile ring
then pinches off the membrane between the two daughter cells, resulting in the
completion of mitosis and formation of two independent daughter cells. A complex signal
transduction pathway dubbed the mitotic exit network tightly regulates the cytoskeletal
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reorganization necessary for cytokinesis to occur (Bardin and Amon, 2001). While the
mitotic exit network has been well described in S. cerevisae and S. pombe (where it is
known as the septation initiation network), the regulatory pathway in higher eukaryotes
remain unclear. Some components that have been identified in higher eukaryotes include
the large tumor suppressor 1 (LATS1), Mob1, and the Rab family of GTPases (Bothos et
al., 2005; Kouranti et al., 2006; Chow et al., 2010).

Factors that can interfere with successful completion of cytokinesis include chromosome
bridging between the newly forming daughter cells. This bridging prevents the
completion of cytokinesis, and if it cannot be resolved, will lead to cleavage furrow
regression and cytokinesis failure. The result of cytokinesis failure is the generation of a
binucleated tetraploid cell. It is thought that following cytokinesis failure, the resulting
tetraploid cell then exits the cell cycle due to a p53-dependent checkpoint in early-G1
phase.

1.2.17 Do Mammalian Cells Possess a Tetraploidy Checkpoint?

There remains a great deal of controversy over whether there is a checkpoint in place
within the G0/G1 phase of the cell cycle to protect against further cycling of tetraploid
cells (Uetake and Sluder, 2004). This checkpoint, located in early-G1, is thought to
prevent further risk for genomic instability caused by altered chromosomal numbers in
the tetraploid cell. p53 deficient cells exhibit increased levels of genomic instability and
polyploidy following mitotic defects, leading some to postulate that the tetraploidy
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checkpoint is p53 dependent (Sphyris and Harrison, 2005; Vitale et al., 2007). Nontransformed cells were demonstrated to arrest in G1 following induction of tetraploidy
dependent on their p53 status, suggesting such a checkpoint does indeed exist
(Andreassen et al., 2001). However, other groups question whether such a checkpoint
exists at all in mammalian cells (Wong and Stearns, 2005).
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1.2 Programmed Cell Death
1.3.1 Programmed Cell Death Overview

Multi-cellular organisms require additional safeguards compared to unicellular organisms
since the health and fitness of the organism as a whole must take precedence over the
survival of an individual cell. As a result, higher eukaryotic organisms have evolved
complex programmed cell death pathways that ensure the death of cells in order to
preserve the organism as a whole. Programmed cell death pathways are involved in
processes as diverse as development to the response to DNA damage from ultraviolet
radiation. The earliest form of cell death to be discovered, necrosis, was described to
occur following tissue injury. For many years, however, it was recognized that a nonnecrotic cell death pathway must exist to account for homeostasis in tissues containing
proliferating cell populations. The earliest forms of this type of cell death were described
as shrinking necrosis and later became known by the current term of apoptosis (Kerr et
al., 1972).

1.3.2 Apoptotic Cell Death

Apoptosis is characterized morphologically by decreased cell size, nuclear envelope
breakdown, chromatin condensation and fragmentation, and membrane blebbing
(Earnshaw, 1995). A primary attribute of apoptosis is that it allows for cell death with
minimal effects on the surrounding tissue. This is because the highly coordinated process
that induces cell death during apoptosis packages intra-cellular contents in such a way
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that they are not released into the extracellular space. This is in contrast to necrosis, a
process in which the cell membrane ruptures, spilling intra-cellular contents in the
extracellular space. The release of intracellular contents induces a massive inflammatory
response and can damage the surrounding tissue.

A critical step in the apoptotic process is permeabilization of the outer mitochondrial
membrane. This permeabilization releases mitochondrial contents into the cytosol
including cytochrome C (Adachi et al., 1997). Cytochrome C, which participates in the
electron transport chain during oxidative metabolism, binds to APAF-1 to form the
apoptosome complex responsible for promoting processing and activation of procaspase
9 (Zou et al., 1997; Cain et al., 2000). Caspase 9 then activates the major effector
caspase, caspase 3, which cleaves a number of proteins to set in place a series of events
that will result in nuclear envelope breakdown, chromatin condensation and degradation
and ultimately, cell death (Li et al., 1997a). For some time, it has been understood that a
network of caspase activation is critical to the apoptotic process (Yuan et al., 1993; Miura
et al., 1993).

1.3.3 Caspases: The Harbingers of Programmed Cell Death

Ced-3, a homolog of Interleuken 1 converting enzyme (ICE), now known as caspase 1,
was the first protease identified as a player in the apoptotic process (Yuan et al., 1993).
Since this discovery, 11 additional caspases have been identified in mammals. These
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caspases play important roles in processes as diverse as apoptosis and cellular
differentiation.

The caspase cleavage network is a complex and highly controlled pathway that involves a
number of distinct caspases that are activated at different stages in the cell death pathway
(Danial and Korsmeyer, 2004). In addition, the specific caspases that are activated
depends on the cell death stimulus. The apoptotic caspases can be loosely grouped into
the initiator caspases (those which cleave/activate of other caspases), and the effector
caspases (those which cleave other proteins to promote apoptosis). The initiator caspases
are caspase 2, 8, 9, and 10. The effector caspases are caspases 3, 6, and 7. While caspase
1 was the first identified pro-apoptotic caspase, it is now thought to be primarily involved
in promoting inflammation (Miller et al., 1995). Caspase 14 is not involved in apoptosis,
but instead promotes keratinocyte differentiation (Eckhart et al., 2000). The functions of
caspases 4 and 5 have not been completely described at this point.

Many substrates of the effector caspases have been described in the literature. For
example, it is well known that caspase 3 binds and cleaves PKCδ to generate a
constitutively active catalytic fragment that will be discussed in depth in section 1.5.9.
Other caspase substrates important for the execution of apoptosis include DNAse
enzymes, PARP, the nuclear lamins and many others (Enari et al., 1998; Lazebnik et al.,
1994; Orth et al., 1996; Zhivotovsky et al., 1997).
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Regulation of apoptosis also occurs at the level of the caspases. The IAP proteins were
identified as anti-apoptotic proteins that function by directly or indirectly inhibiting the
activity of caspases (Clem et al., 1991; Deveraux et al., 1997). For example, XIAP binds
directly to, and inhibits, caspase 9 (Srinivasula et al., 2001). Adding further complexity to
caspase regulation, is the fact that the IAP proteins themselves are regulated by binding
of the SMAC and DIABLO proteins. Binding of SMAC or DIABLO to XIAP prevents
XIAP from inhibiting caspase activity, and thus promotes apoptosis (Du et al., 2000;
Verhagen et al., 2000). In addition to cytochrome C, caspase-independent inducers of
apoptosis are also released from the mitchondria. These include endonuclease G and AIF,
both of which travel to the nucleus and induce chromatin condensation and degradation
(Li et al., 2001; Susin et al., 1999).

1.3.4 Caspases and Cell Cycle Checkpoint Activation

Interestingly, caspases may be important for cellular processes outside of apoptosis. For
example, there is evidence that caspase 2 has an important function in regulating the
G2/M transition following exposure to γ-irradiation. In this study, it was demonstrated
that the loss of caspase 2 activity compromised G2/M checkpoint activation (Shi et al.,
2009). Furthermore, it was demonstrated that after IR exposure, caspase 2 is incorporated
into a complex with DNA-PK and PIDD (which has been previously shown to activate
caspase 2). This complex, dubbed the DNA-PK-PIDDosome, promotes caspase 2
autoprocessing and activation. Interestingly, no substrates for caspase 2 have yet been
identified to explain how it would have influence over cell cycle progression. Caspase 2
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may also be unique amongst caspases in that it is the only caspase with at least partial
constitutive nuclear localization, making it primed to participate in a nuclear DNA
damage response (Zhivotovsky et al., 1999). Supporting a role for caspase 2 in cell cycle
control, it has been demonstrated that the loss of caspase 2 causes an increase in
proliferation and tumorigenicity in Ras/E1A transformed MEFs (Ho et al., 2009).

1.3.5 BCL-2 Family Members

The Bcl-2 family of proteins includes a number of proteins that play both pro- and antiapoptotic roles in the cell. The first family member, Bcl-2, was identified as an oncogene
located at a chromosomal breakpoint in B cell lymphoma (Pegoraro et al., 1984).
Although this putative oncogene had no discernible effect on proliferation, it was soon
discovered that the expression of Bcl-2 conferred resistance to various apoptotic stimuli
(Vaux et al., 1988). Since the discovery of Bcl-2, other pro-survival family members,
including but not limited to Bcl-XL and Mcl-1 have been identified (Boise et al., 1993;
Kozopas et al., 1993). The primary antiapoptotic activity of anti-apoptotic Bcl-2 family
members comes from their ability to bind to Bax and Bak, and prevent the
oligomerization of these pro-apoptotic proteins. By preventing Bax/Bak oligomerization,
the anti-apoptotic Bcl-2 proteins prevent inappropriate permeabilization of the outer
mitochondrial membrane, and thus execution of the apoptotic cascade.

In addition to the pro-survival Bcl-2 family members, a number of pro-apoptotic proteins,
including Bax and Bak have been described (Oltvai et al., 1993). These proteins contain
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oligomerization domains that upon activation can form pores on the outer mitochondrial
membrane, allowing the release of cytochrome C and activation of the apoptosome. The
oligomerization of Bax and Bak is prevented by binding of the pro-survival Bcl-2
proteins, with this interaction representing a key component of their anti-apoptotic
function. The pro-survival family members contain domains BH1-4 which form a pocket
capable of binding the BH3 domains of Bax and Bak, thus preventing their
oligomerization (Muchmore et al., 1996).

1.3.6 Pro-Apoptotic BH3 Only Bcl-2 Family Members

Another class of proteins in Bcl-2 family are the pro-apoptotic BH3-only proteins. The
first BH3 only family member, Bid, was identified as a pro-apoptotic protein that upon
expression could bind to Bax and promote mitochondrial membrane permeabilization
(Wang et al., 1996). Two other important BH3-only proteins are the p53-dependent Noxa
and Puma (Oda et al., 2000; Nakano and Vousden, 2001). Upon activation, p53 binds to
the promoters of these genes and activates their transcription. Other BH3-only proteins
include both BIM and BAD. BH3-only proteins promote apoptosis by disrupting the
interaction between Bcl-2, Bcl-XL, and Mcl-1 with Bax and Bak.

1.3.7 Intrinsic versus Extrinsic Apoptosis

Apoptosis can be classified into at least two general classes depending on the initiating
death stimulus. Extrinsic apoptosis occurs in response to autocrine or paracrine signaling
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via death receptor activation. Death receptors are transmembrane proteins and include
Fas and FADD. Death receptors are activated upon binding of death ligands such as Fas
Ligand, and transmit an intracellular apoptotic signal by stimulating the processing of
pro-caspase 8 zymogen into the cleaved and activated caspase 8 (Kischkel et al., 1995).

In contrast, intrinsic apoptosis occurs in response to intracellular stimuli such as high
levels of DNA damage or oxidative stress. The intrinsic apoptotic pathway involves the
permeabilization of the mitochondria and activation of the apoptosome that was
described in sections 1.2.3 and 1.2.4.

The boundaries between intrinsic and extrinsic apoptosis are not completely clear. For
example, while death receptor induction of caspase 8 is sufficient to induce caspase 3 and
7 activation independent of mitochondrial permeabilization in some cell types, others
require cleavage of Bid to an active truncated form (t-Bid). Cleavage of Bid allows the tBid protein to travel to the mitochondria where it promotes permeabilization by inducing
Bax/Bak oligomerization (Li et al., 1998).

1.3.8 Chromatin Condensation During Apoptosis

During the late stages of apoptosis, the nuclear envelope is broken down via the
phosphorylation and cleavage of lamin B and the chromatin becomes condensed and is
cut into oligo-nucleosomal fragments (Neamati et al., 1995; Enari et al., 1998). The
molecular events behind this condensation are not clearly understood, but warrant further
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investigation. Whether there is a role for histone H3 phosphorylation in apoptotic
chromatin condensation in an analogous manner to that which occurs during prophase of
mitosis is unclear.

The protein Acinus is cleaved by caspases during apoptosis and promotes condensation
of chromatin in the absence of DNA fragmentation, suggesting that chromatin
condensation and degradation are independent during apoptosis (Sahara et al., 1999).
Furthermore, AKT protects against chromatin condensation and apoptosis by
phosphorylating acinus on Ser 422 and 573, thereby preventing caspase cleavage of
acinus during apoptosis (Hu et al., 2005). One group has reported that PKCδ-mediated
phosphorylation of histone H2B on Thr 14 is a critical downstream mediator following
acinus cleavage and activation (Hu et al., 2007). However, the molecular mechanism
behind the importance of H2B phosphorylation and chromatin condensation remains
elusive. Whether other histone phosphorylation events (such as H3 S10 and S28) are
important for chromatin condensation during apoptosis remains unclear.

1.3.9 Mitotic Catastrophe

Mitotic Catastrophe was first characterized in S. pombe as gross abnormalities in
chromosomal segregation that occurred in Cdc2/wee1 mutant strains. This study
demonstrated that mutations in positive regulators of the G2/M checkpoint, such as
cdc25, could suppress this phenotype, implicating inappropriate mitotic entry as a
causative factor (Molz et al., 1989). The hallmark of mitotic catastrophe is the formation
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of polyploid multi-micronucleated cells that arise after several cycles of mitotic failure
and endo-reduplication (Castedo et al., 2002; Castedo et al., 2004a; Erenpreisa et al.,
2005). Whether multi-micronucleated cells are the intended consequence of mitotic
catastrophe, or are a byproduct of an escape from mitotic cell death remains the subject of
much controversy (Castedo et al., 2004b). Cancer cells are often sensitized to cell death
by mitotic catastrophe since they often lack intact cell cycle checkpoints that are
necessary to protect against inappropriate mitotic entry in response to DNA damage (Park
et al., 2005; Eom et al., 2005; Chan et al., 1999; Castedo et al., 2004c). As a consequence
of this sensitivity, the induction of mitotic catastrophe in tumors is an attractive
therapeutic target.
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Chapter 1.4 DNA Damage Responses and Repair
1.4.1 Sources of DNA Damage

Throughout the lifetime of an organism, frequent exposure to DNA damage in various
forms is inevitable. DNA damage can be caused by many different factors including
endogenous factors arising from within the cell and exogenous sources of DNA damage
in the environment. The importance of DNA damage repair is evident in the findings that
many components of DNA repair pathways are mutated in disorders that cause cancer
predisposition. For example, the ATM mutation results in the disorder ataxia
telangiectasia which, among other symptoms causes a sever hypersensitivity to ionizing
radiation exposure (Savitsky et al., 1995a). Furthermore, mutations to the base excision
repair machinery results in a disorder known as xeroderma pigmentosum which is
associated with UV hypersensitivity and increased incidence of skin malignancy (Cleaver
et al., 2009).

All types of DNA damage, however, are not equal in terms of the response elicited by the
cell. In fact, the response and detection of DNA damage within a cell varies depending on
the type and source of DNA damage. For example, exposure to γ-radiation induces
double stranded breaks in the DNA backbone which are recognized differently than the
bulky DNA adducts that occur following exposure to UVB radiation.

1.4.2 The 9-1-1 Complex is Critical for DNA Damage Detection and Repair
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The DNA repair proteins Rad9, Rad1, and Hus1 make up the so called 9-1-1 complex
that is essential for both DNA repair and cell cycle checkpoint integrity (St Onge et al.,
1999; Hopkins et al., 2004). The complex of Rad9, Rad1, and Hus1 forms a
heterotrimeric ring-like complex which acts similarly to PCNA as a clamp. An additional
protein, Rad17, acts as the clamp loading complex for 9-1-1, and is essential for 9-1-1
function (Venclovas and Thelen, 2000). The 9-1-1 complex is multifunctional, in that it is
critical both in activating cell cycle checkpoints by recruiting ATM/ATR to sites of
damage as well as participating directly in DNA repair. Rad9 is also thought to have a
direct role in DNA repair, as it is known to interact with components of the nucleotide
excision repair pathway, such as FLAP endonuclease, and DNA polymerase (FriedrichHeineken et al., 2005; Toueille et al., 2004). Interestingly, the activation of Rad9
following treatment with 5-azacytidine required activation of PKCδ and ATM (Yoshida
et al., 2003).

1.4.3 Nucleotide Excision Repair

The nucleotide excision repair (NER) pathway is critical in the repair of UVB-induced
DNA damage. UVB radiation exposure induces the formation of bulky DNA adducts
within the nucleus. These adducts include pyrimidine dimers and 6,4-photoproducts. If
these adducts are not adequately repaired, they can cause stalling of DNA polymerase
during S-phase resulting in erroneous DNA replication. This can result in hotspot
mutations in tumor suppressor genes like p53 at sites of adjacent pyrimidine nucleotides
(de Gruijl and Rebel, 2008). Mutations in components of the base excision repair
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machinery cause increased skin cancer incidence as a direct result of the inability to
remove UV-induced DNA adducts (Berg et al., 2000).

NER can be divided into two processes, global NER, and transcription-coupled NER.
During global NER, the XPC-Rad23 complex recognizes and binds to distortions in the
DNA double helix caused by bulky DNA adducts (Masutani et al., 1994). Once bound,
XPC recruits XPB and D, components of the TFIIH transcription factor, which unwind
the double helix surrounding the lesion (Drapkin et al., 1994). The endonucleases XPF
and XPG then make incisions in the backbone on either side of the lesion, allowing for
removal of the damaged DNA (Bessho et al., 1997). DNA polymerase then fills in the
excised region using the other strand as a template.

Transcription coupled NER differs in the mechanism by which the damage is recognized.
Rather than relying on the recognition of lesions by XPC, transcription coupled repair
likely begins with stalling of RNA polymerase at the site of the DNA adduct (Mu and
Sancar, 1997). The subsequent steps after recognition are conserved between the two
types of NER. Notably, patients suffering from Cockayne Syndrome have defects in
transcription coupled NER (Schmickel et al., 1977; Venema et al., 1990).

1.4.4 Repair of DNA Double Stranded Breaks: HR Versus NHEJ Pathways

While DNA adducts pose a significant mutagenic risk to a cell, DNA double stranded
breaks are potentially much more deleterious. The presence of DNA double stranded
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breaks can induce genomic instability by leading to chromosomal translocations. Indeed
many cancers, including leukemias, are associated with distinct patterns of chromosomal
translocations. These translocations, in which two chromosomes are fused together at the
site of the double stranded break, can be highly mutagenic depending on their locations
within the chromosomes. For example, in chronic myelogenous leukemia, the reciprocal
translocation of chromosomes 9 and 22 results in the expression of the fusion protein
BCR-ABL, the expression of which is potently oncogenic (Rowley, 1973). Due to the
risk posed to a cell by double stranded breaks, cells have evolved multiple mechanisms
for their detection and repair.

Two repair pathways are critical for the repair of double stranded breaks. These pathways
are non-homologous end joining (NHEJ) and homologous recombination (HR). HR
utilizes homologous DNA sequences to properly align the DNA sequences prior to
ligation. Since this process requires the presence of sister chromosomes, it is thought to
occur only in cells which are in the S, G2, and M phases of the cell cycle. In contrast to
HR, NHEJ is slightly more error prone, but does not require homologous chromosomes
and can therefore function prior to DNA replication.

1.4.5 DNA Dependent Protein Kinase (DNA-PK) is Critical for NHEJ

The recognition of DNA DSBs involves the assembly of the Ku70/80 proteins into a
heterodimeric complex at the sites of the break. The Ku proteins have a high affinity for
exposed DNA ends, and following assembly at the site of damage, act as a scaffold for
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the recruitment of the NHEJ repair machinery (Walker et al., 2001). The presence of Ku
heterodimers at break sites is sufficient to recruit DNA-PK, a kinase related to the ATM
and ATR checkpoint kinases, which is critical for completion of NHEJ (Spagnolo et al.,
2006). Recruitment and activation of DNA-PK is critical for assembly and activation of
enzymes such as Artemis, XRCC4, and DNA ligase IV, all of which are critical for end
processing and ligation (Ahnesorg et al., 2006; Hentges et al., 2006; Goodarzi et al.,
2006; Meek et al., 2007).

1.4.6 BRCA1/2, the MRN Complex and Homologous Recombination

The second mode of DSB repair is homologous recombination. This process utilizes
homologous sister chromosomes to accurately identify and ligate the appropriate DNA
ends, and involves distinct protein complexes from those involved in NHEJ. The MRN
complex consists of Mre11, Rad50, and Nbs1 (Xiao and Weaver, 1997). The importance
of this complex to DNA repair is evident in patients suffering from Nijmegen Break
Syndrome, a genetic disease associated with Nbs1 mutations that results in massive
genetic instability. Following DNA DSB formation the MRN complex is recruited to the
break site via direct interaction of Mre11 with the exposed DNA end (de Jager et al.,
2001b; de Jager et al., 2001a). Following assembly at the break site, The MRN complex
then process the DNA ends to expose RPA coated stretches of single stranded DNA for
use in subsequent steps of HR-mediated repair (Trujillo and Sung, 2001).
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Also critical to the HR repair process are the tumor suppressor Brca proteins. The Brca1
and 2 genes have been identified in hereditary breast cancers, in which individuals
carrying Brca mutations have an elevated risk for developing breast cancer (Castilla et
al., 1994; Thorlacius et al., 1998). Brca1 and 2 are clearly important for homologous
recombination, as cells with impaired Brca1 or Brca2 function have depleted levels of
HR following DNA damage (Moynahan et al., 2001b; Moynahan et al., 2001a; Chen et
al., 1999a).
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Chapter 1.5 Protein Kinase C Signaling and Biology
1.5.1 Protein Kinase C Family of Serine/Threonine Kinases

Protein kinase C was first discovered in bovine brain extracts as a proteolytically
activatable kinase (Inoue et al., 1977). The protein kinase C (PKC) family consists of at
least 9 isoforms which differ in pattern of tissue expression and overall signaling biology.
The 9 isoforms can be further separated into the classical isoforms, novel isoforms, and
atypical PKC isoforms. PKC isoforms play diverse roles in processes including cellular
differentiation, proliferation, apoptosis, and migration. The human epidermis expresses
5 distinct PKC isoforms, α, δ, , η, and  (Denning, 2004).

1.5.2 The Classical PKC Isoforms

The classical PKC isoforms were the first PKC isoforms to be identified, and include
PKCα, PKCβ, and PKCγ. Classical PKC isoforms are activated by intracellular Ca2+
release from the endoplasmic reticulum in response to binding of inositol triphosphate to
the inositol triphosphate receptor. In addition to activation by Ca2+, classical PKC
isoforms are activated by binding to diacylglycerol. Inositol triphosphate and
diacylglycerol are generated when phospholipase C cleaves phosphatidyl inositol
bisphosphate following phosphorylation of phosphatidyl inositol by phosphatidyl inosito3 kinase (PI3K) (Berridge and Irvine, 1984).
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Interestingly, the lone classical PKC isoform expressed in the human epidermis is PKCα.
As there is a positive Ca2+ gradient in the epidermis, it is interesting to note that PKCα
has been demonstrated to play a critical role in the induction of differentiation induced
cell cycle withdrawal (Jerome-Morais et al., 2009).

1.5.3 The Novel PKC Isoforms

The novel PKC isoforms include PKCδ, PKCε, PKCη, and PKCθ (Ono et al., 1987).
Unlike the cPKC isoforms, nPKCs do not respond to Ca2+ stimulus as they contain a C2like domain that varies significantly from the Ca2+ responsive C2 domain of the classical
PKC isoforms (Pappa et al., 1998). nPKC isoforms do, however, retain responsiveness to
diacylglycerol stimulation. The precise function of the C2-like domain of PKCδ remains
unclear, but it has been purported to bind to and enable actin redistribution in neutrophils
(Lopez-Lluch et al., 2001). In addition, the C2-like domain of PKCδ has been
demonstrated to bind to phospho-tyrosine residues, enabling phosphorylation specific
interactions with other proteins (Benes et al., 2005). In contrast to the anti-proliferative
effects of PKCδ, PKCε promotes proliferation (Cacace et al., 1996). The positive role for
PKCε in proliferation is bolstered by the finding that PKCε transgenic mice are more
susceptible to formation of squamous cell carcinoma when treated with the DMBA/TPA
carcinogenesis regimen (Reddig et al., 2000; Jansen et al., 2001). While PKCε is a
potential oncogene, another novel PKC isoform, η, localizes to the granular layer of the
epidermis and is important for normal epidermal differentiation (Koizumi et al., 1993;
Osada et al., 1993; Cabodi et al., 2000).
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1.5.4 The Atypical PKC Isoforms

The third class of PKC isoforms, the atypical PKCs include PKCζ and PKCι/λ (Ono et
al., 1987; Ono et al., 1989; Selbie et al., 1993). These isoforms are perhaps the least well
understood of the three classes and lack responsiveness to either Ca2+ or diacylglycerol.
In the epidermis, PKCζ has been implicated in establishing cell polarity and in the
formation of intercellular tight junctions (Helfrich et al., 2007; Izumi et al., 1998).

1.5.5 Structural Domains of Protein Kinase C

PKCs are multi-domain proteins, and the domain makeup of each PKC class differs
(Figure 3). Generally, the structure of PKC proteins can be broken down into the
regulatory and catalytic domains, each of which constitutes roughly half of the protein.
The PKC catalytic domain contains the C3 and C4 domains (Newton, 1997). The C4
domain of PKC provides the protein with its catalytic activity and substrate binding
domain. The C3 domain of PKC binds to ATP, bringing it in proximity to the catalytic
site in the C4 domain allowing for transfer of the γ-phosphate of ATP to PKC substrates.

There is a great deal of variation between PKC isoforms in the makeup of the regulatory
domain of the protein. Classical PKC isoforms contain a calcium binding C2 domain in
the regulatory domain of the protein. The C2-like domain of the novel PKC isoforms
lacks Ca2+ responsiveness, but likely confers unique substrate binding properties for these
isoforms. Both classical and novel, but not atypical PKC isoforms contain phorbol ester

48
binding C1b domains (Hunn and Quest, 1997). These allow the protein to localize to the
membrane upon activation where it can interact with and phosphorylate a variety of
downstream effectors.

Another key structural component of protein kinase C is the pseudosubstrate domain.
Thus far, every PKC isoform, with the possible expception of PKCμ contains a
pseudosubstrate domain in within the regulatory domain of the protein (House and Kemp,
1987). Under conditions in which PKC is inactive, the pseudosubstrate binds to the
substrate binding catalytic site of PKC, and inhibits PKC activity. Mutation to the
psudosubstrate domain, or disruption of pseudosubstrate domain binding using blockin
antibodies is sufficient to induce PKC activity, indicating the importance of this
intramolecular interaction in preventing inappropriate PKC activation (Pears et al., 1990;
Makowske and Rosen, 1989). Upon activation of PKC, the interaction of the
pseudosubstrate domain and the catalytic domain is disrupted, thus freeing the catalytic
site to phosphorylate PKC targets.
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Caspase Cleavage

Figure 3 – Structural Domains of the Protein Kinase C Family. Shown above
is the basic domain makeup of the classical, novel, and atypical PKCs.
The C1A and B domains provide binding to diacylglycerol and phorbol
esters and are present on novel and classical isoforms. The C2 domain
binds Ca2+ and is incomplete in the novel isoforms. The PB1 domain of
the atypical PKCs is thought to mediate protein-protein interactions.
Also labeled is the caspase cleavage site that is unique to PKCδ among
all PKC isoforms.
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1.5.6 The Novel PKC isoform, δ

Protein Kinase C δ was first cloned from a rat brain cDNA library using probes designed
to recognize classical PKC isoforms (Olivier and Parker, 1991). Further characterization
led to the classification of PKCδ as being unresponsive to Ca2+ stimulation and
predominantly expressed in the murine epidermis and other epithelial tissues, as well as
the brain (Leibersperger et al., 1991). The characterization of human PKCδ followed
shortly after the discovery of this isoform in rats and mice (Aris et al., 1993). PKCδ
protein has a molecular weight of approximately 78 kDa. PKCδ tends to phosphorylate
substrates on the following consensus sequence:

S/TXXR/K

(X represents any amino acid residue)

PKCδ is unique among PKC isoforms in several ways. First, PKCδ contains a conserved
nuclear localization sequence (NLS) within the C4 domain (DeVries et al., 2002). Several
groups have reported the importance of nuclear translocation of PKCδ during apoptosis
(Scheel-Toellner et al., 1999; Yoshida et al., 2003; Eitel et al., 2003). In addition, it has
been demonstrated that mutation of this nuclear localization sequence abrogates the
ability of PKCδ to induce apoptosis (DeVries et al., 2002; DeVries-Seimon et al., 2007).
The importance of the NLS for PKCδ pro-apoptotic activity suggests that there are key
substrates for PKCδ within the nucleus. Interestingly, the V5 region of PKCδ has also
been reported to regulate PKCδ sub-cellular localization, suggesting that other factors
than the putative NLS may control nuclear translocation of PKCδ (Wang et al., 2004).

51
Another unique aspect of PKCδ is that it is capable of undergoing activation
independently of membrane localization (Steinberg, 2004). This may be, at least in part,
due to activation of PKCδ by caspase cleavage.

PKCδ contains a conserved caspase cleavage site within the hinge region that separates
the regulatory and catalytic domains of the protein. This cleavage event generates a
constitutively activated catalytic fragment of approximately 40 kDa in molecular weight
(Emoto et al., 1995). The fate of the regulatory domain of PKCδ following caspase
cleavage is not well understood. This caspase cleavage site and the associated biological
functions of PKCδ cleavage will be discussed below.

PKCδ protein function varies significantly depending on the tissue and cellular context.
For example, PKCδ expression is lost in many squamous cell carcinomas and PKCδ has a
well characterized role in promoting apoptosis (Reyland et al., 1999; Reyland et al.,
2000; Matassa et al., 2001; Carpenter et al., 2002; Denning et al., 2002; Lasfer et al.,
2006). In contrast, PKCδ expression has been associated with poor prognosis in breast
cancers (McKiernan et al., 2008). Additionally, PKCδ activity was demonstrated to be a
pro-survival protein in some breast cancer cell lines (McCracken et al., 2003).
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1.5.7 Post-Translational Mechanisms of PKCδ Regulation

Full length PKCδ activity is extensively modulated by a number of phosphorylation
events that occur on serine, threonine, and tyrosine residues located throughout the
protein. PDK1 phosphorylates PKCδ on Thr505 of the activation loop to prime the
protein for activation (Le Good et al., 1998; Balendran et al., 2000; Flynn et al., 2000).
This PDK1-mediated phosphorylation promotes the autophosphorylation of Ser 643 and
662, generating a catalytically competent “mature” PKCδ protein (Li et al., 1997b;
Stempka et al., 1999). It is important to note that while these phosphorylation events are
critical for the maturation of PKCδ to a catalytically competent protein, they do not
activate the full length protein in the absence of other stimuli/phosphorylation events.

In addition to serine and threonine phosphorylation, PKCδ can also be extensively
phosphorylated on key tyrosine residues located throughout the protein (Denning et al.,
1993; Li et al., 1994). Tyrosine phosphorylation of PKCδ can be catalyzed by the Src
family of tyrosine kinases (Gschwendt et al., 1994; Zang et al., 1997). In addition,
tyrosine phosphorylation is stimulated by activation of the epidermal growth factor
receptor (EGFR) (Denning et al., 1996; Denning et al., 2000; Bossi et al., 2008a).
Tyrosine phosphorylation sites on PKCδ that have been identified include Tyr 187, 311,
332 (Szallasi et al., 1995; Li et al., 1996; Blake et al., 1999; Lu et al., 2007b; Lu et al.,
2007a). Whether the tyrosine phosphorylation of PKCδ activates or inhibits the kinase
activity of PKCδ remains the subject of controversy (Denning et al., 1993; Fukunaga et
al., 2001; Blass et al., 2002). In keratinocytes, the expression of oncogenic ras induces
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tyrosine phosphorylation and inhibition of PKCδ activity (Denning et al., 1993).
Interestingly, phosphorylation at Tyr311 and 332 may modulate caspase cleavage due to
the proximity to the caspase cleavage site in the hinge region.

1.5.8 Alternative Splicing of PKCδ

In addition to being regulated at the transcriptional and post-translational levels, PKCδ
can also be regulated by alternative splicing. To date, eight different PKCδ splice variants
have been identified in different species. Although the function of the various isoforms
has yet to be clearly described, at least some of the variants may display resistance to
caspase cleavage. For example, the PKCδ II and VIII isoform cannot be cleaved by
caspase 3, and appear to be anti-apoptotic in function (Sakurai et al., 2001; Jiang et al.,
2008). PKCδVIII expression, for example, is capable of rescuing NT2 cells from
etoposide-induced apoptosis.

1.5.9 Caspase Cleavage of PKCδ

PKCδ is unique among PKC isoforms in that is proteolytically activated by caspase
cleavage during apoptosis in many cell types (Emoto et al., 1995; Ghayur et al., 1996;
Denning et al., 1998). Occuring on highly conserved aspartic acid residues (see below),
this cleavage generates a constitutively active catalytic fragment, PKCδ-cat, by
separating the regulatory and catalytic domains of PKCδ. This catalytic fragment has
been convincingly demonstrated to be both necessary and sufficient for UV-induced
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apoptosis. For example, the ectopic expression of the PKCδ-cat is sufficient to induce
apoptosis in human keratinocytes (Denning et al., 2002). Conversely, expression of a
cleavage resistant PKCδ mutant protects cells against UV-induced apoptosis, suggesting
that the cleavage of PKCδ is a critically important step in the apoptotic cascade (D'Costa
and Denning, 2005).

PKCδ Conserved Caspase Cleavage SequenceDMQD330N

The primary caspase responsible for cleaving PKCδ has been reported to be caspase 3,
although it has also been reported that caspase 2 can also cleave PKCδ at this region
(Panaretakis et al., 2005).

It is likely that in addition to conferring constitutive catalytic activity to the PKCδ
catalytic domain, caspase cleavage also allows access to a host of new substrates as
PKCδ activity no longer requires phorbol ester binding following cleavage. This cleavage
therefore generates a soluble pool of activated PKCδ-cat that may phosphorylate proteins
that are not phosphorylated by the membrane bound full length PKCδ (Denning et al.,
1998).

1.5.10 PKCδ is a Critical Mediator of Apoptosis

Protein Kinase Cδ is critically important for a diverse range of functions within the
human body. In the epidermis, and many other tissues, PKCδ is necessary and sufficient
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for the induction of apoptosis in response to a wide variety of stimuli and therefore has
important tumor suppressive function. This work, largely using cell culture, has been
extended into PKCδ null mice, where it was demonstrated that the loss of PKCδ confers a
resistance to etoposide or γ-irradiation induced apoptosis (Humphries et al., 2006).

A great deal of effort has been exerted toward understanding the downstream substrates
of PKCδ that make this protein so important for the apoptotic cascade. This work has
yielded insight into many interesting targets of PKCδ signaling that may explain why this
protein is so potently pro-apoptotic. For example, the PKCδ has been shown to
phosphorylate and activate p53 on Ser 15 and 46 (Lee et al., 2006; Yoshida et al., 2006a).
In addition to regulating p53 activation at the post-translational level, PKCδ has also been
implicated in the transcriptional activation of p53 via induction of the apoptotic protein
Btf (Liu et al., 2007). PKCδ has also been implicated in the regulation of the p53 family
member, p73 during apoptosis (Ren et al., 2002). In addition, PKCδ also phosphorylates
Mcl-1, to promote Mcl-1 degradation and Bax activation during UV-induced apoptosis
(Sitailo et al., 2004; Sitailo et al., 2006). PKCδ activity is also important for nuclear
envelope breakdown during apoptosis, since PKCδ functions as an apoptotic lamin kinase
(Cross et al., 2000). The pro-apoptotic role of PKCδ also likely reflects PKCδ-mediated
induction of p38 signaling (Tanaka et al., 2003).

It has also been postulated that PKCδ activity stimulates an pro-apoptotic autocrine
signaling loop via the induction of TRAIL and TNFα signaling (Gonzalez-Guerrico and
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Kazanietz, 2005). Interestingly, at least in LNCaP prostate cancer cells, this pro-apoptotic
function appears to be independent of PKCδ cleavage (Fujii et al., 2000).

1.5.11 PKCδ and Regulation of the Cell Cycle

In addition to regulating apoptosis, PKCδ also has a role in regulating cell cycle
progression following DNA damage. Over-expression studies have demonstrated that
PKCδ can induce cell cycle arrest at multiple stages in the cell cycle. For example, PKCδ
overexpressing Chinese hamster ovary cells underwent a cell division arrest in mitosis
following phorbol ester stimulation (Watanabe et al., 1992). Subsequent work
demonstrated that the inhibition of cytokinesis by PKCδ likely involves the inhibition of
Lats1, an integral component of the mitotic exit network (Takahashi et al., 2006). In
addition, the treatment of metastatic melanoma cells with TPA results in inhibition of
Cdk1 and a G2/M arrest, although the specific PKC isoforms involved in this arrest were
not identified (Arita et al., 1998).

Besides regulating progression through the G2 and M phases of the cell cycle, PKCδ has
also been implicated in regulating the G1/S phase of the cell cycle. PKCδ was shown to
induce p27 and delay cyclin D expression following serum stimulation of quiescent rat
microvascular endothelial cells (Ashton et al., 1999). Treatment of anaplastic human
thyroid cancer cells with TPA induced a G1 arrest associated with upregulation of p21
and p27, and this effect could be blocked by siRNA mediated depletion of PKCδ
(Afrasiabi et al., 2008). Similar work in lung adenocarcinoma cells demonstrated TPA
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induced G1 arrest was dependent on PKCδ but not PKCα, and was associated with
upregulation of p21 (Nakagawa et al., 2005). Conversely, in Wistar rat thyroid cells,
PKCδ has been demonstrated to induce apoptosis by first inducing G1 progression
followed by S phase arrest (Santiago-Walker et al., 2005).

1.5.12 PKCδ and the DNA Damage Response

PKCδ has recently been implicated in the DNA damage response where it was
phosphorylated and activated by ATM following treatment with 5-azacytidine and
subsequently phosphorylated and activated Rad9 to promote DNA repair (Yoshida et al.,
2003). Interestingly, PKCδ was also discovered downstream of ATM in the activation of
NF-κB transcription following UV-irradiation, making PKCδ a bona-fide target of ATM
following DNA damage (Ravi et al., 2007). Specific ATM phosphorylation sites in PKCδ
remain to be indentified.

In contrast to the positive role in DNA repair, PKCδ may also act as a signal to shut down
DNA repair pathways. It was reported that PKCδ-cat phosphorylates and inactivates
DNA-PK during apoptosis (Bharti et al., 1998). Since shutdown of repair mechanisms is
known to occur during apoptosis, DNA-PK may be an additional substrate important for
PKCδ apoptotic activity.
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1.5.13 PKCδ as a Tumor Suppressor

Given the importance of PKCδ to apoptosis, cell cycle regulation, and DNA repair, it is
not entirely surprising that PKCδ has been identified as a putative tumor suppressor. In
human squamous cell carcinomas, the expression of PKCδ is lost, and the re-expression
of PKCδ in SCC cell lines suppresses their tumorigenicity (D'Costa et al., 2006).
Furthermore, PKCδ transgenic mice are resistant to both skin papilloma and squamous
cell carcinoma formation in response to treatment with the DMBA-TPA carcinogenesis
regimen (Reddig et al., 1999). Interestingly, while PKCδ transgenic mice were resistant
to the chemical carcinogenesis regimen, they showed no resistance to a UV
carcinogenesis regimen (Aziz et al., 2006). This surprising finding could illustrate a true
discrepancy between the requirement for PKCδ as a tumor suppressor in chemical versus
UV carcinogenesis, or it may be an indication that the endogenous levels of PKCδ are
sufficient for UV tumor suppression. If the latter is true, then increasing PKCδ levels
would not be expected to have an additional protective effect over that provided by the
endogenous protein. In addition, PKCδ levels were reduced in the SCCs generated by UV
radiation, suggesting that even in the transgenic mice, PKCδ expression was lost during
tumorigenesis. In order to address this question further, the use of PKCδ knockout mice
should be utilized with the UV carcinogenesis regimen to determine whether the loss of
PKCδ function confers susceptibility to SCC formation.

The loss of PKCδ in squamous cell carcinomas likely occurs at the transcriptional level
(Yadav et al., 2010). PKCδ expression is also lost or decreased in a number of other
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cancer types, including endometrial, and colon cancer (Reno et al., 2008; Kahl-Rainer et
al., 1994; Craven and DeRubertis, 1994). In contrast, PKCδ is overexpressed in
mammary tumors and is associated with metastatic progression (Kiley et al., 1999a; Kiley
et al., 1999b). How PKCδ can be both oncogenic and tumor suppressive remains to be
determined.
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1.6 Significance

While PKCδ clearly functions as a tumor suppressor in the skin, the mechanism of tumor
suppression by PKCδ is not completely understood. Here, we seek to investigate and
characterize additional tumor suppressor mechanisms of PKCδ in relation to G2/M cell
cycle regulation and apoptosis. By gaining a better understanding of PKCδ function in
the epidermis, we may be able to identify new therapies in the treatment of squamous cell
carcinomas of the skin. Further characterization of the PKCδ signaling network will aid
in the development of treatments that could restore PKCδ expression, or activation of
important downstream effectors whose regulation may be altered in the absence of PKCδ
signaling.
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Chapter 2
Materials and Methods

2.1 Retroviral Constructs, Packaging, and Infection

PKCδ-GFP, PKCδ(D327A)-GFP, and PKCδ(K376R)-GFP constructs were graciously
provided by Dr. Mary E. Reyland (University of Colorado Health Sciences Center) and
were previously described (DeVries et al., 2002). These constructs were sub-cloned in
XhoI/NotI sites of the LZRS-Linker retroviral expression vector for infection of cultured
KCs and mouse embryonic fibroblasts (MEFs). LZRS-PKCδ-cat-FLAG, and the 4hydroxytamoxifen-activatable LZRS-PKCδ-cat-ER were previously described (Sitailo et
al., 2004). A diagram of the LZRS-Linker retroviral plasmid is displayed in Figure 4.
Please note that the multiple cloning site used for subcloning of PKCδ constructs into the
LZRS-Linker plasmid is located between the 5’ and 3’ long terminal repeat sequences
(LTR). Upon infection with the LZRS retrovirus the LTR sequences, along with any
intervening sequences, are incorporated randomly into the genome of the infected cell.
The 5’ LTR then drives transcription of the target gene of interest.

Retroviral supernatant was generated by calcium phosphate-mediated transfection of
Phoenix-Ampho packaging cells as described previously (Sitailo et al., 2002). Following
transfection, Phoenix-Ampho cells were positively selected for plasmid incorporation by
treatment with 10 ng/mL puromycin until the culture dishes reached approximately 75%
confluency. Phoenix-Ampho cells were then refed with DMEM minus puromycin and
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incubated at 32 °C overnight to generate retrovirus. Retroviral infection of target cells
using Phoenix-Ampho retroviral supernatant was done for 1 hr at 1200 rpm and 32°C.
Schematic diagrams of the PKCδ full length and catalytic fragment constructs used in this
study are displayed in Figure 5.

2.2 Cell Culture and UV Treatment

Primary human KCs were isolated from neonatal foreskins with Loyola Institutional
Review Board approval as described previously (Mitra and Nickoloff, 1994; Tibudan et
al., 2002). KCs and HaCaT cells were cultured in Medium 154CF with 0.07 mM calcium
and HKGS (Cascade Biologics). Spontaneously immortalized MEFs from wild type or
PKCδ null mice were cultured in DMEM (Invitrogen) containing 10% fetal bovine
serum, and were kindly provided by Dr. Anning Lin (University of Chicago). PKCδ-catER was activated by treatment with 10 µM 4-hydroxytamoxifen (Alexis Biochemicals)
(Sitailo et al., 2004). In all experiments using PKCδ-cat-ER, control (Linker) transduced
cells were also treated with 4-hydroxytamoxifen. ATM/ATR inhibition was achieved by
the addition of 2 mM caffeine in water to the culture medium (Sarkaria et al., 1999). The
inhibition of Aurora kinases was achieved by the addition of 10 μM Aurora Kinase
Inhibitor II (189404, Calbiochem) in the culture medium. UV irradiation was done using
a UV Panelite Unit with approximately 65% emission in the UVB spectrum as previously
described (D'Costa et al., 2006).
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MCS
Xho I (11460)
EcoRI (11448)
HindIII (11436)

Not I (1)

BamHI (11424)

Sal I (18)
NheI (96)

BglII (11055)

3' LTR

psi
5'LTR

DUC

NheI (9574)

LZRS Linker

AMPR

puroR
SalI (2522)

11475 bp

PGP
ClaI (3246)

EBNA

criP
Figure 4 – LZRS-Linker Plasmid Map. Shown above is a schematic of the
LZRS-Linker plasmid used in the subcloning and retrovirus generation
of all PKCδ constructs used within this document. Please note the
mltiple cloning site (MCS) is located between the 5’ and 3’ LTR
sequences, resulting in the incorporation of the target sequence upon
retroviral recombination into the genome of infected cells. The puroR
construct allows for selection of transfected Phoenix-Ampho cells
using puromycin.
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Figure 5–Retroviral PKCδ Constructs. Schematic diagrams of the PKCδ
constructs used throughout this document. PKCδ-cat indicates the PKCδ
catalytic fragment. ER is the estrogen receptor ligand binding domain.
GFP is green fluorescent protein.
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2.3 Cell Cycle Synchronization

For mitotic synchronization experiments, HaCaT cells were treated with 10 ng/mL
nocodazole for 18 hours to induce metaphase arrest (Chou and Omary, 1994). Cells were
released from nocodazole arrest by removal of media, washing in PBS, and refeeding
with nocodazole-free 154CF containing 10 μM 4-hydroxytamoxifen. Exit from mitosis
was monitored using propidium iodide staining and FACS analysis as described in the
flow cytometry section of this Chapter. An increased percentage of cells with 2N DNA
content was interpreted to mean that successful completion of mitosis had occurred.

For G1/S synchronization, cells were treated for 18 hrs with the DNA polymerase
inhibitor aphidicolin at a concentration of 10 μM (Berger et al., 1979; Pedrali-Noy et al.,
1980). Following incubation, cells were released by removing the media, washing with
PBS, and refeeding with aphidicolin-free 154CF plus 10 μM 4-hydroxytamoxifen.
Progression through S phase was measured by propidium iodide staining and FACS
analysis.

2.4 siRNA Transfection of HaCaT Cells

HaCaT cells were transfected with control (SC-37007, Santa Cruz) or PKCδ siRNA (SC44229, Santa Cruz) using the Lipofectamine 2000 transfection reagent (11668,
Invitrogen) in antibiotics-free 154CF. HaCaT cells were plated at a density of 100,000
cells per well in a 6-well plate the day prior to transfection. The next day, 100 pmol of
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siRNA per well was combined with 250 μL of Opti-MEM serum free medium and mixed
gently. Meanwhile, 5 μL per well of Lipofectamine 2000 was diluted in 250 μL OptiMEM and incubated at room temperature for 5 min. After incubation, the diluted
Lipofectamine 2000 solution was mixed with the diluted siRNA solution, and incubated
at room temperature for 20 min. 500 μL of the Lipofectamine/siRNA solution was added
to each well containing 1.5 mL of Opti-MEM and the HaCaT cells. After overnight
incubation, cells were washed and refed with normal 154CF media. 48 hrs after
transfection, cells were collected for flow cytometry to measure apoptosis, and Western
blot analysis to verify successful knockdown of PKCδ.

2.5 Antibodies and Western Blotting

Cell lysates were collected by scraping cells in RIPA buffer (50 mM Tris, pH 7.5, 150
mM NaCl, 1% Triton X-100, 0.1% SDS, 1% Sodium Deoxycholate). Lysates were
briefly sonicated and centrifuged at 14,000 rpm for 5 min to remove cellular debris.
Protein concentrations were determined using standard Bradford Reagent methodology.
Antibodies used for Western blotting include: Actin (69100, MP Biomedical), Cdc25A
(SC-97, Santa Cruz) Cdk1 (SC-747, Santa Cruz), Phosphorylated Cdk1(Y15) (SC7989R, Santa Cruz), γH2A.X (UBI 05-636, Upstate), Histone H3 (ab1791, Abcam),
Phosphorylated histone H3(S10) (UBI 06-570, Upstate), P~p53(S15) (9284S, Cell
Signaling), PKCδ (SC-937, Santa Cruz) (610397, BD), Rad9 (SC-74464, Santa Cruz), αtubulin (UBI 05-829, Upstate), and Vinculin (V4505, Sigma). Secondary antibodies used
for Western blotting were goat anti-rabbit IgG-Alexa Fluor 680 (A21076, Invitrogen),
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donkey anti-rabbit IgG-IRDye 800 (611-732-127, Rockland) and goat anti-mouse IgG
conjugated to AlexaFluor-680 (A21057, Molecular Probes) and donkey anti-mouse IgG
IRDye 800 (610-732-124, Rockland) for detection using the LI-COR infrared scanning
system (LI-COR Biosciences).

2.6 Recombinant PKCδ-cat Kinase Reaction

To generate recombinant PKCδ-cat, 400 ng of active caspase 3 (201-038-C005; Alexis
Biochemicals) was incubated with 200 ng of recombinant full length PKCδ (Panvera
Corp) in caspase assay buffer (25 mM HEPES pH 7.4, 0.25 M sucrose, 2 mM EDTA, 2.5
M DTT) for 30 min at 37 ºC. 25 ng of full length or cleaved PKCδ was then incubated
with 1 μg of recombinant histone H3 (New England Bio) in PKC kinase buffer (50 mM
Tris-HCl, pH 7.4, 250 mg/mL BSA, 1 mM EDTA, 1.5 mM MgCl2, 25 mM ATP, 1
mg/mL 4:1 phosphatidyl choline:phosphatidyl serine, 10 nM 12-O-tetradecanoylphorbol13-acetate) then incubated at 30 ºC for 30 min. To measure histone H3 Ser 10
phosphorylation, reactions were subjected to SDS-PAGE Western blot analysis using
anti-P~H3(S10) primary antibody.

2.7 Flow Cytometry

Cells were collected by trypsinization, pelleted and washed in FACS buffer (phosphate
buffered saline, 5% fetal bovine serum). Cells were then pelleted and resuspended in 100
µL of FBS. Cells were fixed by addition of ice-cold 100% ethanol for at least 30 minutes.
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RNA was digested by treatment with 10 µg/mL RNAse for 15 minutes at 37°C.
Propidium iodide was added to a final concentration of 50 µg/mL and samples were
incubated on ice for at least 1 hr. Cell cycle profiles were analyzed using a Beckman
Coulter EPICS XL-MCL flow cytometer. Histogram overlays were generated using
FlowJo software.

2.8 Phospho~H3(S10)/DNA PI Staining and Mitotic Index

For mitotic index measurements in MEFs, the cells were treated with or without UV
followed by 10 ng/mL nocodazole to trap any cells that had overcome UV-induced G2/M
arrest and entered mitosis. Mitotic index measurements in HaCaT cells were performed 3
days after PKCδ-cat-ER transduction, and thus were not treated with nocodazole. Cells
were collected and washed in FACS buffer before being fixed in 3.7% formaldehyde for
10 minutes. After fixation, cells were permeabilized in 70% EtOH at 4 °C for 30 min.
After washing in FACS buffer, cells were incubated for 2 hrs in 100 μL of P~H3(S10)
antibody. Cells were washed and incubated on ice in 100 μL of diluted Alexa Fluor-488
anti-rabbit secondary for 30 min. Following secondary antibody incubation, cells were
washed twice and incubated in 500 μL of solution containing 10 µg/mL RNAse and 50
µg/mL PI for 30 minutes prior to FACS analysis.
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2.9 Immunofluorescent Staining and Confocal Microscopy

Cells were cultured on glass coverslips, fixed in 3.7% formaldehyde, and permeabilized
with 0.1% Triton X-100. Alternatively, for staining with certain antibodies, cells grown
on coverslips were fixed and permeabilized using ice-cold acetone/methanol (1:1).
Following fixation, coverslips were washed in FA buffer then incubated with primary
antibody diluted in goat serum to block non-specific binding for 1 hr. Following primary
antibody incubation, coverslips were washed in FA buffer and incubated in secondaryfluorophore conjugated secondary antibody diluted 1:400 in goat serum for 1 hr. After
staining with primary and secondary antibodies, coverslips were washed in FA then
incubated in 100 ng/mL DAPI for 5 min to stain chromatin. Coverslips were mounted
onto slides using Gelvatol. Images were generated using a Carl Zeiss LSM-510 confocal
microscope with 1 µm optical slice at 40x magnification or an Olympus AX80
epifluorescent microscope, equipped with a QImaging Retiga 4000R digital camera.
Secondary antibodies used for immunfluorescent microscopy were goat anti-rabbit IgGAlexa Fluor 488 (A11008, Molecular Probes) and 568 (A11036, Molecular Probes) and
goat anti-mouse IgG-Alexa Fluor 488 (A11001, Molecular Probes) and 568 (A21144,
Molecular Probes).

2.10 Chromosomal Spreads

Primary keratinocytes were plated into 6-well dishes for retroviral infection with LZRSLinker or LZRS-PKCδ-cat-ER retrovirus. Cells were infected the day after plating, and
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treated with 10 μM 4-hydroxytamoxifen the day following infection. 3 days postinfection, cells were collected by trypsinization, pelleted, and resuspended in 5 mL
hypotonic buffer (75 mM KCl) to induce cell swelling. Cells were incubated in hypotonic
buffer at room temperature for 30 minutes, and then pelleted. Cells were resuspended and
fixed in 3.7% formaldehyde for 10 minutes. Following fixation, cells were pelleted and
permeabilized in 1% Triton X detergent for 10 minutes. Cells were pelleted and
resuspended in 300 μL PBS and pelleted onto microscope slides using a cytospin. After
allowing slides to dry, cells were stained with α-P~H3(S10) antibody for 1 hr at room
temp, followed by staining of the chromatin with 100 ng/mL DAPI.

2.11 Nuclear/Cytoplasmic Fractionation

Cells were collected in PBS and incubated in hypotonic buffer (10 mM KCl, 50 mM
HEPES pH 7.9, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, Complete Protease Inhibitor
(Roche) and 40 mM glycerophosphate, 2 mM sodium fluoride, and 1 mM sodium
orthovanadate) for 15 min on ice. Triton-X 100 was added to a final concentration of
0.5% to complete lysis. Samples were centrifuged and the resulting supernatant contained
enriched cytoplasmic proteins. The pellet (containing nuclei) was washed in hypotonic
buffer plus 1 M sucrose and lysed in high-salt buffer (400 mM KCl, 50 mM HEPES pH
7.0, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1 mM DTT, Complete Protease Inhibitor
and phosphatase inhibitors). Samples were centrifuged, and the resulting supernatant
contained enriched nuclear proteins.
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2.12 Thymine Dimer Southwestern Blot

WT and PKCδ null MEFs were plated into p100 tissue culture dishes. Cells were then
exposed to 75 mJ/cm² UV radiation. At the indicated times, DNA was harvested from
cells by scraping the cells into 500 μL of DNA lysis buffer (10 mM Tris-HCl pH = 7.8, 5
mM EDTA, 0.3 M NaOAC, 1% SDS, 20 μg/mL proteinase K). Protein digestion was
performed by incubating lysates overnight at 55 ºC. Following overnight incubation, 500
μL of phenol/chloroform/isoamyl alcohol (25:24:1) was added to each tube with shaking
for 2 minutes. Tubes were spun in eppendorf centrifuge at 13,000 rpm for 10 minutes.
The aqueous layer (containing DNA) was transferred to a fresh tube, and 1 mL of icecold 100% EtOH was added to precipitate DNA. Tubes were spun at 13,000 rpm for 2
min to pellet DNA, and EtOH was carefully decanted following centrifugation. DNA
pellets were then resuspended in 300 μL of TE buffer.

After resuspension, DNA concentrations were measured using a UV spectrophotometer.
In preparation for sample loading, 200 ng of DNA were added to a final volume of 500
μL of TE. DNA was denatured by incubation at 100 ºC for 10 min. Using a slot blot
apparatus, samples were applied to Hybond-N+ membrane (Amersham) using vacuum
pressure to pull TE through the membrane. After loading, membrane was allowed to dry.
DNA was then crosslinked to the membrane using 70,000 J of UVC in a UV stratalinker.
After crosslinking, the membrane was blocked overnight using Odyssey blocking buffer
(LI-COR Biosciences). Membranes were then incubated in α-thymine dimer primary
antibody overnight,washed for 15 min in TBS, followed by goat anti-rabbit IgG-Alexa
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Fluor 680 (A21076, Invitrogen) for 1hr. Following secondary antibody incubation, the
membrane was washed in TBST for 1hr then scanned using Licor infrared scanner.
Densitometry was done using Licor software, and intensities were corrected by removing
the background membrane intensity.

2.13 Crystal Violet Staining

For focus forming assays, WT and PKCδ null MEFs were plated in p100 tissue culture
dishes at low density. Cells were cultured to confluent conditions, and maintained at
confluency for 7 days. To visualize confluency-induced colony formation, cells were
fixed in 3.7% formaldehyde for 5 minutes at room temperature, and then stained with
0.05% crystal violet stain for 5 minutes. Plates were then washed extensively in water to
decrease background staining. After allowing plates to airdry, images were generated
using a flatbed scanner.

2.14 Soft Agar Colony Formation Assay

PKCδ null MEFs were plated into 6-well dishes for infection with LZRS-PKCδ-GFP
retrovirus. Three days post-infection, media/soft agar mixture was prepared by combining
40 mL of 2x DMEM with antibiotics, 10 mL FBS, and 40 mL of melted 44 °C, 1.25%
Difco agar for a final concentration of 0.5% agar medium. 1 mL of prepared DMEM-agar
medium was poured into each well of a 6-well plate and allowed to solidify at room
temperature for 30 min. Meanwhile, PKCδ null control MEFs, and PKCδ null MEFs
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expressing PKCδ-GFP were resuspended to a final concentration of 100,000 cells per mL
of DMEM-agar medium, and 1 mL of this suspension was added on top of each well.
Cells were then grown in soft agar over 10 days then stained using a 1 mg/mL solution of
p-iodonitrotetrazolium violet (INT) staining to label metabolically active colonies. 500
μL of INT solution was added on top of each well, and plates were incubated at 37 °C
overnight. Labelled colonies were counted using a bright field microscope.
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Chapter Three
The PKCδ catalytic fragment induces multiple cell cycle checkpoints

3.1 Ectopic Expression of PKCδ-cat Induces G2/M Cell Cycle Arrest

Many tumor suppressors have critical roles in both the regulation of apoptosis and cell
cycle regulation (ie. p53, ATM and ATR). This tight link between cell cycle regulation is
not entirely suprising considering that there are common stimuli between the two
responses. For example, DNA damage can potently induce both cell cycle checkpoint
activation and apoptosis. Furthermore, the onset of apoptosis is often preceded by a
period of cell cycle arrest while the cell attempts to repair the damaged DNA. Since the
two processes are so tightly intertwined, there should be proteins which share regulation
over both pathways.

These proteins are expected to play important roles in tumor

suppression, as the misregulation of either cell cycle checkpoints or apoptosis promote
genomic instability and tumor development.

As discussed in Chapter 1.5.13, PKCδ is a known tumor suppressor in many cancer
types, including squamous cell carcinoma. The importance of PKCδ for squamous cell
carcinoma tumor suppression likely reflects, at least in part, the key role for PKCδ in the
apoptotic cascade of keratinocytes.

However, like p53 and many other tumor

suppressors, PKCδ has also been reported to regulate cell cycle progression in many cell
types, but whether the ability of PKCδ to regulate cell cycle progression is important for
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PKCδ-mediated tumor suppression is unclear (Watanabe et al., 1992; Takahashi et al.,
2006; Arita et al., 1998).

While the role of the PKCδ in apoptosis has been extensively studied little is understood
about the role of PKCδ in regulating cell cycle progression, particularly with regards to
G2/M checkpoint activation (Watanabe et al., 1992; Takahashi et al., 2006; Arita et al.,
1998). To determine the effect, if any, of the PKCδ catalytic fragment (PKCδ-cat) on the
cell cycle, we retrovirally expressed PKCδ-cat or an inducible PKCδ-cat/estrogen
receptor fusion protein (PKCδ-cat-ER) in cultured primary human KCs, HaCaT cells
(Figure 4), and MEFs (Figure 7A). Propidium iodide staining revealed that PKCδ-cat
expression increased G2/M KCs approximately 2-fold (p<0.005) compared to the control
Linker virus population (Figure 5A and B). PKCδ-cat expression had a similar effect on
the immortalized HaCaT cell line, which harbors mutant p53, although the effect was
slightly diminished (Lehman et al., 1993). A similar but diminished effect was also
detected in WT and PKCδ null MEFs, suggesting that the effect of PKCδ-cat on the cell
cycle is present in multiple species (Figure 7B). Surprisingly, in these experiments, we
did not detect a significant induction of apoptosis (ie. cells with sub-G1 DNA content)
following PKCδ-cat induction.

To distinguish between arrest in G2 or M, mitotic index measurements were performed
on PKCδ-cat-ER transduced HaCaT cells by measuring P~H3(S10) levels and DNA
content. Using this procedure, cells in mitosis should stain positively for P~H3(S10) and
have 4N DNA content. In this experiment, a decrease in mitotic index would indicate that
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PKCδ-cat is inducing G2/M arrest outside of mitosis, while an increase in mitotic index
would indicate a mitotic arrest. Figure 6A and 6B show that PKCδ-cat-ER causes a
significant (p<0.001) reduction in mitotic cells, indicating that PKCδ-cat-ER induces a
G2/M rather than mitotic arrest.

Linker PKCδcat-ER

Linker PKCδ-cat

PKCδ

PKCδ FL

Estrogen
Receptor

96 kD
66 kD
96 kD

PKCδ CF

PKCδ

66 kD

Figure 4–Ectopic Expression of PKCδ-cat-FLAG and PKCδ-cat-ER Proteins.
Western blots displaying relative levels of full length (PKCδ-FL) and catalytic
fragment (PKCδ-cat) of PKCδ protein are shown in control Linker, PKCδ-catFLAG, and PKCδ-cat-ER transduced KCs. PKCδ-cat-ER transduced cells
display a strong estrogen receptor, ER, positive band at the same position as the
PKCδ protein, indicating successful expression of the ER fusion protein.
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HaCaT

7–PKCδ-cat Induces G2/M Cell Cycle Arrest in Primary
Keratinocytes and HaCaT Cells. A) Representative DNA content
histograms of primary KCs and HaCaT cells transduced with either Linker
(gray) or PKCδ-cat-ER (white) retrovirus are shown. Propidium iodide staining
was performed 2-3 days following infection. Similar results were obtained in at
least 3 independent experiments. B) Quantitation of the percentage of cells
containing G2/M DNA content in KCs and HaCaT cells 2-3 days after infection
with either Linker control or PKCδ-cat-ER retrovirus. Graphs represent
experiments done in triplicate. * Student’s t-test value of p<0.005.
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Figure 8–PKCδ-cat Induces a Decrease in Mitotic Index in HaCaT Cells
A) HaCaT cells transduced with either Linker or PKCδ-cat-ER retrovirus
were harvested and stained for P~H3(S10) and propidium iodide after 3
days, and analyzed by flow cytometry. B) Quantitation of mitotic indices
from HaCaT cells treated as in A. ** Student’s t-test value of p<0.001.
Error bars denote the standard deviation.
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Figure 9 –PKCδ-cat-ER induces G2/M Cell Cycle Arrest in WT and PKCδ
Null MEFs. A)Western Blot showing retrovirally transduced
expression of PKCδ-cat-ER in wild type and PKCδ null MEFs. B)
Wild type and PKCδ null MEFS were transduced with either Linker or
PKCδ-cat-ER retrovirus, and after 3 days stained with PI and DNA
content was measured using flow cytometry. The percentage of cells in
the G2/M phase of the cell cycle is shown. * Student’s t-test value of
p<0.01
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3.2 PKCδ-cat Expression Induces G2/M Checkpoint Signaling

Since many of the components that positively and negatively regulate G2/M cell cycle
progression are localized to the nucleus, it is likely that PKCδ-cat would need to have at
least some nuclear localization to participate in the G2/M checkpoint. In addition, it has
been reported by several groups that upon exposure to various apoptotic stimuli, PKCδ
translocates to the nucleus, and this nuclear translocation is critical for the apoptotic
function of PKCδ (Scheel-Toellner et al., 1999; Yoshida et al., 2003; Eitel et al., 2003).

To examine PKCδ sub-cellular localization, we performed nuclear/cytoplasmic
fractionation on HaCaT cells before and 18 hours after exposure to 30 mJ/cm² UV
radiation. Fractionation results revealed that both the full length PKCδ and PKCδ-cat
were present in the nucleus, with PKCδ-cat detected only after UV exposure (Figure 8A).
The decrease in levels of the full length PKCδ after UV exposure are likely a
consequence of UV-induced cleavage of PKCδ. UV radiation caused a significant
fraction of histone H3 to be detected in the cytoplasmic extract, suggesting apoptotic
degradation of the nuclear membrane occurred in the cells exposed to UV radiation.
Confocal microscopy using a carboxyl-terminal GFP fusion of PKCδ (PKCδ-GFP) and
DAPI staining was used to confirm the sub-cellular fractionation data. PKCδ-GFP was
localized to both the cytoplasm and nucleus before and after UV irradiation (Figure 8B).
This localization provides a means by which PKCδ may interact with important
components of the G2/M cell cycle checkpoint pathway.
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We next tested whether PKCδ-cat induced molecular changes consistent with G2/M
checkpoint activation. One key aspect of this checkpoint involves the phosphorylation of
Cdk1 on tyrosine 15 by Wee1 and Myt1 kinases, an event which has been shown to
inhibit Cdk1 activity and prevent entry into mitosis (Parker et al., 1995; Parker and
Piwnica-Worms, 1992; Piwnica-Worms et al., 1991; Mueller et al., 1995; Booher et al.,
1997). We measured relative levels of P~Cdk1(Y15) in PKCδ-cat expressing KCs and
found that PKCδ-cat expression induced elevated levels of P~Cdk1(Y15) compared to
the control Linker-transduced cells. The PKCδ-cat kinase dead (K378A) mutant did not
induce P~Cdk1(Y15) (Figure 9). As a positive control, UV radiation also induced
P~Cdk1(Y15).

PKCδ signaling is known to promote the production of reactive oxygen species (ROS),
and elevated intracellular levels of ROS can induce oxidative DNA damagne (Bossi et
al., 2008b). The induction ROS following PKCδ-cat expression might then induce
indirect checkpoint activation by causing oxidate damage to DNA. If this were true, and
PKCδ-cat-induced G2/M checkpoint activation occured by stimulating DNA damage,
then inhibition of ATM and ATR, two genes critical for recognizing DNA damage and
activating cell cycle checkpoints, should block PKCδ-cat induced cell cycle arrest. To
examine this, we treated primary human KCs and HaCaT cells ectopically expressing the
PKCδ-cat-ER with 2 mM caffeine, a known inhibitor of ATM and ATR (Figure 10)
(Sarkaria et al., 1999). Interestingly, we found that inhibition of ATM/ATR activity by
caffeine treatment did not block PKCδ-cat induced G2/M arrest in primary KCs or
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HaCaT cells. This finding provides substantial evidence that PKCδ-cat induced G2/M
checkpoint activation occurs independently of ATM/ATR signaling.
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Figure 10–PKCδ Protein Levels are Present in both Cytoplasm and Nucleus
Before and After UV irradiation. A) Western blot showing levels of
PKCδ protein in cytoplasmic and nuclear extracts of untreated or 30
mJ/cm² UV exposed KCs after 18 hrs. The full length (FL) and catalytic
fragment (CF) of PKCδ are indicated by arrows. Vinculin and histone H3
are presented as cytoplasmic and nuclear markers, respectively. B)
Confocal microscope images were taken showing cytoplasmic and nuclear
staining of PKCδ-GFP fusion protein both before and 18 hrs after exposure
to 30 mJ/cm² UV radiation. DAPI staining is displayed to demonstrate
nuclear localization. Images were taken using 40x objective and 1 µm
optical slice. Scale bar denotes 25µm.
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Figure 11–UV and PKCδ-cat Expression Cdk1 Induce Tyrosine
Phosphorylation. Western blot showing levels of P~Cdk1(Y15),
total Cdk1, and PKCδ after retroviral transduction of either PKCδcat-ER, PKCδ-cat, or the kinase dead PKCδ(K378A)-cat-ER. The
PKCδ-cat-ER fusion proteins run to the same position in the gel as
the full length PKCδ. KC lysate harvested 18 hrs after exposure to
30 mJ/cm² UV radiation is shown as a positive control for
P~Cdk1(Y15) induction. Actin protein levels are displayed as a
loading control. n.s. indicates the detection of a non-specific band
on the Western Blot.
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Figure 12–PKCδ-cat Induced G2/M Arrest Occurs Independently of
ATM/ATR.PI cell cycle analysis of LZRS-Linker or LZRS-PKCδcat-ER transduced primary KCs and HaCaT cells incubated with 2
mM caffeine and 10 μM 4 OH-Tamoxifen for 48 hours. The
percentage of cells in G2/M phase of the cell cycle is displayed from
experiments performed in triplicate. * Student’s t-test value of p<105
; # Student’s t-test value of p<10-4.
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3.3 PKCδ Controls Multiple Cell Cycle Checkpoints

To further investigate the role for PKCδ in controlling overall cell cycle progression, we
utilized the cell cycle synchronizing agents nocodazole, and aphidicolin. The
combination of these agents with our PKCδ-cat-ER tamoxifen-inducible constructs
allowed us to specifically activate PKCδ-cat-ER activity at various cell cycle stages, and
determine whether PKCδ-cat could influence cell cycle progression in cell cycle stages
other than G2/M.

Nocodazole, a microtubule depolymerizing agent causes cells to arrest in mitosis by
activating the spindle assembly checkpoint (Chou and Omary, 1994). The subsequent
removal of nocodazole from the culture medium allows cells to form mitotic spindles and
complete chromosomal segregation and mitosis. It has been reported by several groups
that PKCδ is a negative regulator of cytokinesis (Watanabe et al., 1992; Takahashi et al.,
2006). To investigate whether PKCδ-cat expression can induce late-stage mitotic arrest,
we treated Linker and PKCδ-cat-ER expressing HaCaT cells with nocodazole overnight
to arrest cells at metaphase. The next day, between 70-85% of cells had arrested within
mitosis based on DNA content and observed cell morphology. Next, we simultaneously
released the cells from metaphase arrest and treated with 4-hydroxytamoxifen to activate
the PKCδ-cat-ER fusion protein. Cells were harvested at various time points post-release
to measure the return of both cell populations to 2N DNA content, indicative of the
successful completion of mitosis.
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Strikingly, while Linker infected control HaCaT cells were able to largely recover from
nocodazole arrest, complete mitosis, and return to G1 phase, PKCδ-cat-ER activation
significantly prevented HaCaT cells from completing mitosis (Figure 11). This was
evidenced by the maintenance of 4N DNA content in the PKCδ-cat-ER experimental
group. This suggests that in addition to regulating the G2/M checkpoint, and in
agreement with previously published work, PKCδ also plays a role in regulating
progression through the late stages of mitosis.

In addition to nocodazole-mediated mitotic synchronization, we utilized the DNA
polymerase inhibitor aphidicolin to arrest cells in the G1/S phase of the cell cycle (Berger
et al., 1979; Pedrali-Noy et al., 1980). Upon overnight incubation of both Linker and
PKCδ-cat-ER infected HaCaT cells with 10 μM aphidicolin, approximately 70-75% of
cells were arrested in G1 or early S phase (Figure 12). The removal of aphidicolin from
the culture medium allowed cells to resume DNA replication, progress through S phase
and enter into G2 and mitosis. As in our nocodazole release experiments, we
simultaneously removed aphidicolin and treated with 4-hydroxytamoxifen to activate
PKCδ-cat-ER. We then measured the progression of cells through S phase and into G2/M
by collecting at various timepoints, and staining with propidium iodide.

Strikingly, while Linker cells successfully completed S phase, entered mitosis, and began
to return to G1 over the time, PKCδ-cat-ER cells entered S phase, but never progressed
through S phase into G2 (Figure 12). This can conclusion can be observed by the
diminished increase in the percentage of PKCδ-cat-ER trancduced cells with G2/M DNA
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content after aphidicolin release (Linker: 15% after arrest increased to 40% 9 hours after
release; PKCδ-cat-ER: 10% after arrest increased to less than 20% after release).
Similarly, following the initial entry into S-phase following aphidicolin release, PKCδcat-ER cells appear unable to accumulate, as only approximately 2-3% exit S-phase and
enter G2/M phase based on DNA content analysis. These results indicate that PKCδ-cat
can impede progression through S-phase, and are consistent with the recent finding that
PKCδ could stimulate premature G1 phase cell cycle progression followed by S phase
arrest and apoptosis (Santiago-Walker et al., 2005).

89

90

Percentage of Cells in G2/M

80

Linker
PKCd-cat-ER

70
60
50
40
30
20
10
0
0

8

16

Time of Release (hrs)

Figure 13–PKCδ-cat-ER Activation Delays Mitotic Exit After Release from
Nocodazole Induced Metaphase Arrest. Linker (solid) and PKCδcat-ER (dashed) transduced HaCaT cells were incubated with 10
ng/mL nocodazole overnight to induce metaphase arrest. Cells were
then washed and refed with nocodazole-free media + 10 μM 4hydroxytamoxifen to activate PKCδ-cat-ER. Cells were collected at
indicated timepoints, fixed and stained with propidium iodide to
measure DNA content.

24

90
Linker
50
G2/M

45
40

Percent cells in

35
S

30
25
20

G1

15
10
5
0
0

7

8

9

Release Time (hrs)
PKCδ-cat-ER
60

S

50

Percent Cells in

40

30
G2/M
20

G1

10

0
0

7

8

9

Release Time (hrs)

Figure 14–PKCδ-cat-ER Activation Delays Progression Through S-phase
After Release from Aphidicolin Arrest. Linker and PKCδ-cat-ER
transduced HaCaT cells were incubated with 10 μM aphidicolin
overnight to induce G1/S phase arrest. Cells were then washed and
refed with aphidicolin-free media + 10 μM 4-hydroxytamoxifen to
activate PKCδ-cat-ER. Cells were then collected at indicated
timepoints, fixed and stained with propidium iodide to measure DNA
content. Error bars represent the standard deviation from the mean of
the experiment done in triplicate.
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Chapter 4
PKCδ is Required for UV-Induced G2/M Checkpoint Activation

4.1 UV-Induced G2/M Cell Cycle Arrest Requires PKCδ

Since expression of PKCδ-cat was capable of inducing a pronounced G2/M arrest and
checkpoint activation in KCs and HaCaT cells, we next determined the requirement for
PKCδ in DNA damage-induced cell cycle arrest. To address this issue, wild type and
PKCδ null MEFs were exposed to UV radiation (Figure 13 and 14). We found that
exposure of the wild type MEFs to 30 mJ/cm² UV radiation induced a pronounced G2/M
arrest which persisted up to 24 hours after exposure (Figure Figure 14 and 15). Strikingly,
UV exposure failed to induce G2/M arrest in PKCδ null MEFs although there was a
slight increase in the percentage of cells in S phase. The slight increase in the percentage
of cells in the G2/M phase of the cell cycle 12 hours following UV-irradiation may be a
reflection of an initial PKCδ-independent G2/M arrest (Figure 15 and 17). Importantly,
PKCδ null MEFs did undergo a G2/M arrest when transduced with PKCδ-cat-ER virus,
indicating that they were competent to arrest in G2/M (Figure 7).

Mitotic indices were measured by staining for P~H3(S10) levels (a known marker of
mitosis) and DNA content. Measurement of mitotic indices revealed that UV caused a
significant (p<0.05) decrease in mitotic wild type MEFs, but not PKCδ null MEFs, at 6
hours, indicating that the UV-induced arrest was in G2 (Figure 16). In contrast, when
mitotic indices were gathered 1 hr after UV exposure, both WT and PKCδ null MEFs
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displayed a comparable decrease in mitotic index (Figure 17). This suggests that PKCδ is
not required for early UV-induced G2/M arrest, but that maintenance of the G2/M arrest
over time requires PKCδ. G2/M checkpoint activation compared to maintenance in the
response to DNA damage has been described for other proteins, including p53, and will
be elaborated upon in the discussion.

Interestingly, G2/M checkpoint override by the ATM/ATR inhibitor caffeine drove UVirradiated wild type MEFs into apoptosis (as measured by sub-G1 DNA content), but did
not induce apoptosis in PKCδ null MEFs (Figure 18). The lack of apoptosis after
caffeine-mediated inhibition of checkpoint activation in PKCδ null MEFs is likely a
reflection of the crucial pro-apoptotic functions of PKCδ. Interestingly, PKCδ null cells
treated with UV plus caffeine accumulated in S-phase (p<10-4), indicating a possible Sphase checkpoint independent of PKCδ and ATM/ATR function.

We were also interested in the requirement of PKCδ in the cell cycle response to other
forms of DNA damage. Ionizing radiation exposure induces both double and single
stranded DNA breaks, and is well known to be a potent inducer of G2/M cell cycle arrest.
We decided to use ionizing radiation as a source of DNA damage in our MEF system to
determine the effect of PKCδ loss on G2/M checkpoint response. As occurred following
exposure to UV radiation, WT MEFs underwent a pronounced G2/M cell cycle arrest
following exposure to low (4 Gy) and high (20 Gy) doses of γ-radiation (Figure 19).
Similar to the response to UV radiation, PKCδ null MEFs exposed to 4 Gy of γ-radiation
had a dimished G2/M cell cycle arrest compared to WT MEFs. Strikingly, even after
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exposure to high doses of γ-radiation (20 Gy), PKCδ null MEFs demonstrated a
diminished ability to undergo G2/M arrest. This finding suggests that PKCδ is important
for the G2/M checkpoint response to both UV and ionizing radiation.

It will be

interesting to determine the universiality of PKCδ in the G2/M checkpoint response to
other types of DNA damage (ie. ROS, inter-strand crosslinks, etc...).

MEF
WT

PKCδ
PKC
Null

PKCδ
γ -Tubulin

Figure 15–PKCδ Protein Levels in WT and PKCδ Null MEFs. Western blot
displaying PKCδ protein levels in wild type (WT) and PKCδ null MEF
whole cell lysates. α-Tubulin levels are shown as a loading control.
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Figure 16–WT, but not PKCδ Null MEFs Undergo a G2/M Cell Cycle Arrest
Following Exposure to UV Radiation. A) Representative DNA content
histograms of WT and PKCδ null MEFs before and 18 hrs after exposure
to 30 mJ/cm². B) The percentage of WT and PKCδ null MEFs in the
G2/M phase of the cell cycle before and after exposure to 30 mJ/cm² UV
radiation is displayed. Error bars denote the standard deviation of the
mean from experiments performed in triplicate. * Student’s t-test value
of p<0.005.
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Figure 17–PKCδ Null MEFs Fail to Arrest in G2/M Over 24 Hours
Following UV-Radiation Exposure. The percentage of WT and PKCδ
null MEFs with G2/M DNA content at various times following
exposure to 30 mJ/cm² UV radiation is displayed. Error bars denote the
standard deviation of the mean from experiments performed in
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Figure 18–UV Induces a Decrease in Mitotic Index in WT but not PKCδ Null
MEFs A) WT and PKCδ null MEFs were exposed to 10 mJ/cm2 UV and
treated with 100 ng/mL nocodazole and stained for P~H3(S10) and
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after exposure to 30 mJ/cm² UV radiation, cells were collected, and
mitotic index was determined by flow cytometry. Note the apparent
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apoptosis. WT and PKCδ null MEFs were exposed to 30 mJ/cm² UV
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γ-Irradiation Induced G2/M Arrest in Wild Type and PKCδ Null MEFs
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Figure 21–γ-Radiation Induces a G2/M Arrest in WT and PKCδ Null MEFs
WT and PKCδ null MEFs were exposed to 4 or 20 Gy γ-radiation.
Cells were collected 18 hrs after irradiation, and DNA content w as
analyzed. The percentage of cells in the G2/M phase is displayed .
Error bars denote the standard deviation of the mean from experiments
performed in triplicate. * Student’s t-test value of p<10-4; ** Student’s
t-test value of p<0.0005, # Student’s t-test value of p<0.001; @
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4.2 UV-Induced G2/M Arrest Requires PKCδ Cleavage and Kinase Activity

We next attempted to rescue G2/M checkpoint integrity in PKCδ null MEFs by
retrovirally transducing them with the catalytically competent full-length PKCδ-GFP
(Figure 20). To address whether PKCδ kinase activity or caspase cleavage are required to
restore the G2/M checkpoint response, we also transduced a kinase dead mutant,
PKCδ(K376R)-GFP, or a kinase competent mutant that possesses a mutated caspase
cleavage site, PKCδ(D327A)-GFP. All PKCδ-GFP constructs were expressed at similar
levels (Figure 20). Expression of PKCδ-GFP in PKCδ null MEFs had little effect on the
cell cycle distribution of non-damaged cells (Figure 21). As expected, expression of
PKCδ-GFP in PKCδ null MEFs restored the G2/M checkpoint response to UV radiation
suggesting the altered cell cycle response of PKCδ null MEFs was a direct consequence
of PKCδ loss of function (Figure 21). In contrast, the kinase dead PKCδ(K376R)-GFP
mutant was not able to restore the G2/M checkpoint in the PKCδ null MEF background,
indicating that kinase activity is necessary for this PKCδ checkpoint function. Strikingly,
expression of the cleavage site mutant PKCδ was also unable to restore UV-induced
G2/M arrest in the PKCδ null MEFs (Figure 21). This suggests that PKCδ cleavage is a
critically important event in the enforcement of the G2/M checkpoint after exposure to
UV radiation. The dose of UV radiation (30 mJ/cm²) used in these experiments was
sufficient to induce caspase 2 and 3 activity, both of which are capable of cleaving PKCδ
(unpublished results from Dr. Leonid Sitailo).
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4.3 UV-induced G2/M checkpoint activation requires PKCδ

We next examined components of the G2/M checkpoint pathway before and after UV
exposure in wild type and PKCδ null MEFs. In agreement with the cell cycle analysis in
Figures 14-16, we found that UV exposure induced G2/M checkpoint activation as
assessed by increased levels of P~Cdk1(Y15) in wild type but not PKCδ null MEFs
(Figure 22). In agreement with the cell cycle data presented in Figure 21, re-expression of
PKCδ-GFP, but not either the PKCδ kinase dead or caspase cleavage mutant PKCδ,
restored phosphorylation of P~Cdk1(Y15) after UV exposure (Figure 22). This supports
the idea that both kinase activity and caspases cleavage of PKCδ are important events in
the activation of the G2/M checkpoint after DNA damage.

Despite lacking an intact G2/M checkpoint response, PKCδ null MEFs exhibited UVinduced γH2A.X and P~p53(S15), both of which are direct substrates of ATM and ATR
kinases (Figures 22 and 23). This indicates that ATM/ATR are activated successfully in
PKCδ null MEFs, but that there is a disruption in downstream signaling when PKCδ is
lost. Successful activation of ATM/ATR in PKCδ null MEFs reinforces the findings in
Figure 10, that PKCδ-cat affects the G2/M checkpoint downstream, or independently of
ATM and ATR. Furthermore, the treatment of MEFs with caffeine partially repressed the
UV-induced phosphorylation of p53(S15), supporting the direct role of ATM and ATR in
this phosphorylation event (Figure 23). Please note that the slightly repressed levels of
γH2AX induction after UV in the PKCδ null MEFs were not reproducible between
multiple experiments.
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In an attempt to identify a known cell cycle regulator that was misregulated in PKCδ null
MEFs, we performed immunofluorescent staining for Cdc25A in WT and PKCδ null
MEFs (Figure 24). Misregulation of Cdc25A after UV exposure could be one explanation
for the inability of PKCδ null MEFs to phosphorylate Cdk1(Y15) in response to DNA
damage. However, despite the fact that PKCδ null MEFs lack an intact G2/M DNA
damage checkpoint they appeared to regulate Cdc25A in the same way as WT MEFs. In
both WT and PKCδ null MEFs, Cdc25A was sequestered in the cytoplasm after UV
radiation exposure (Figure 24). The possibility remains that PKCδ may be responsible for
regulating a different Cdc25 isoform, as the misregulation of one isoform would be
sufficient to block elevated levels of P~Cdk1(Y15) (Varmeh and Manfredi, 2009).
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Figure 22–Expression of PKCδ-GFP Fusion Proteins in PKCδ Null MEFs.
WT and PKCδ null MEFs were untransduced, or transduced with either
WT PKCδ-GFP, the cleavage resistant PKCδ(D327A)-GFP, or the
kinase inactive PKCδ(K376R)-GFP and exposed to 30 mJ/cm² UV.
Protein lysates were analyzed for expression of PKCδ and Actin.
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Figure 23–WT PKCδ, but not Caspase Resistant or Kinase Dead PKCδ
Rescues G2/M Checkpoint Function in PKCδ Null MEFs. A)
Representative DNA content histograms of WT and PKCδ null MEFs
before and 18 hrs after exposure to 30 mJ/cm² UV radiation. B) The
percentage of WT and PKCδ null MEFs in G2/M after transduction
with the indicated PKCδ-GFP fusion protein before and after exposure
to 30 mJ/cm² UV radiation is displayed. Error bars denote the standard
deviation of the mean from experiments performed in triplicate. *
Student’s t-test value of p<0.005.
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Figure 24–WT PKCδ but not Caspase Resistant or Kinase Dead PKCδ
Mutants restores Cdk1(Y15) Phosphorylation After UV. WT and
PKCδ null MEFs expressing PKCδ-GFP, PKCδ(D327A)-GFP, or
PKCδ(K376R)-GFP were exposed to 10 mJ/cm² UV radiation. Protein
lysates were collected 18 hrs after irradiation and analyzed for levels of
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experiments.
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Figure 25–Phosphorylation of Checkpoint Proteins 6hrs after UV Irradiation
in WT vs. PKCδ-/- MEFs. WT and PKCδ null MEFs were exposed to
10 mJ/cm² UV radiation and protein lysates were collected after 6
hours for detection of the phosphorylation status of p53, γH2AX, and
Cdk1. Note the suppression of P~p53(S15) and γH2AX levels by
caffeine, indicating successful inhibition of ATM/ATR activity.
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Figure 26 Both Wild Type and PKCδ Null MEFs. A)WT and B) PKCδ null
MEFs were exposed to 30 mJ/cm² UV radiation. Cells were fixed and
stained for Cdc25A protein 18 hours post UV exposure. Images are
taken at 40x magnification using an epifluorescent microscope.
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Chapter 5
The PKCδ Catalytic Fragment Induces Phosphorylation of Histone
H3(S10)

5.1 PKCδ-cat Induces Histone H3(S10) Phosphorylation in Interphase Cells

While investigating PKCδ-cat-induced G2/M arrest within G2 and mitosis we discovered
that while PKCδ-cat expression blocks mitotic entry by stimulating activation of the
G2/M checkpoint, it also results in the induction of histone H3(S10) phosphorylation
(Figure 25). Massive phosphorylation of Histone H3 Ser 10 and 28 occurs during
prophase and is tightly linked with mitotic chromatin condensation, so an increase in
P~H3(S10) levels would seem to indicate a mitotic rather than G2 arrest. While this
result at first seemed contradictory to our work showing PKCδ-cat induced G2 arrest, it
became clear upon further investigation that PKCδ-cat-induced phosphorylation occurred
in cells that lacked the characteristic morphological features of mitotic cells (Figure 26).
That is, they did not present with mitotic chromatin, they lacked any semblance of a bipolar mitotic spindle apparatus, and they maintained intact nuclear lamina (Figures 26
and 27).
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To confirm that PKCδ-cat induced histone H3 phosphorylation outside of mitosis, we
utilized a pharmacologic approach to inhibit Aurora B, the kinase responsible for
phosphorylating histone H3(S10) during the prophase of mitosis (Giet and Glover, 2001;
Goto et al., 2002). Strikingly, while inhibition of Aurora B almost completely abrogated
P~H3(S10) levels in the Linker control cells, it caused no significant change in the
PKCδ-cat induced P~H3(S10) (Figure 28). To directly determine the cell cycle status of
PKCδ-cat-induced P~H3(S10) positive cells, we simultaneously measured P~H3(S10)
levels and DNA content using propidium iodide. While P~H3(S10) positive cells were
almost completely restricted to the G2/M phase in Linker cells, we discovered that
PKCδ-cat expression induced a significant percentage of P~H3(S10) positive cells with
both interphase and mitotic DNA content (ie. 2N, 4N and intermittent content) (Figure
29). Together, these findings demonstrate that PKCδ-cat induces P~H3(S10) outside of
mitosis, and independently of the mitotic H3 kinase, Aurora B.

In addition to mitotic H3 phosphorylation by Aurora B, several other kinases, including
IKKα, MSK3 and 6, and Fyn have been implicated as Histone H3 kinases in interphase
cells (Duncan et al., 2006; Yamamoto et al., 2003). To investigate whether PKCδ-cat
may be directly phosphorylating Histone H3(S10) we decided to test the ability of
recombinant PKCδ-cat to phosphorylate histone H3 on Ser10 in vitro. We utilized
recombinant PKCδ and recombinant active caspase 3 to generate constitutively activated,
recombinant PKCδ-cat. We next incubated this reaction with recombinant histone H3 and
non-radiolabelled ATP and subsequently analyzed histone H3(S10) phosphorylation by
Western blot. Strikingly, PKCδ-cat, and to a lesser extent, full length PKCδ were able to
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phosphorylate histone H3 on Ser 10 in vitro, raising the possibility that PKCδ may be a
histone H3 kinase in the cell (Figure 30). It remains possible that the PKCδ
phosphorylation in vitro may be an artifact of the reaction conditions and further
experiments are needed to verify that PKCδ is a true H3 kinase.

111

Linker

PKCδcat PKCδcat
KDFLAG
FLAG

P~H3(S10)

PKCδ

Actin

Figure 27– Expression of PKCδ-cat-ER induces phosphorylation of histone
H3 on Ser10. Primary keratinocytes were retrovirally transduced with
either Linker, PKCδ-cat-FLAG or the kinase dead PKCδ-catKDFLAG. 1 day post-infection, all cells were treated with 10μM 4hydroxytamoxifen to induce activation of ER fusion proteins. Protein
lysates were collected 3 days post-infection and subjected to Western
blot analysis of protein levels with the indicated antibodies.
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Figure 28– PKCδ-cat-Induced P~H3(S10) Positive Cells Lack Mitotic
Morphology. Primary keratinocytes were retrovirally transduced with
either Linker, or PKCδ-cat-ER. 1 day post-infection, all cells were
treated with 10μM 4-OH tamoxifen to induce activation of ER fusion
proteins. 3 days post-infection, cells were fixed and stained with the
indicated antibodies. Arrows indicate P~H3(S10) positive cells.
Pictures taken at 40x magnification. Inlayed images are displayed at
160x.
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Figure 29– PKCδ-cat Induced P~H3(S10) Positive Cells Have Intact Nuclear
Envelopes. Linker and PKCδ-cat-ER infected keratinocytes were
treated with 10μM 4-hydroxytamoxifen. Cells were fixed 3 days after
infection and stained with anti-P~H3(S10) and anti-Lamin B2. Arrows
indicate P~H3(S10) positive nuclei. Note the intact nuclear envelope in
PKCδ-cat-ER induced P~H3(S10) positive cells. * represents a
P~H3(S10) positive Linker infected cell with an intact nuclear
envelope that is likely in prophase, prior to nuclear envelope
breakdown. Images were taken at 40x magnification.
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Figure 30– Inhibition of Aurora Kinase does not Block PKCδ-cat Induction
of P~H3(S10). Linker and PKCδ-cat-ER infected keratinocytes were
treated with 10μM 4-hydroxytamoxifen with or without 10μM Aurora
Kinase inhibitor. Cells were fixed 3 days after infection and stained
with anti-P~H3(S10) and anti-α-tubulin. Pictures displayed at 20x
magnification. A) Representative images showing the failure of AKI
treatment to prevent PKCδ-cat induced P~H3(S10). B). Percentage of
P~H3(S10) positive cells per 20x field. 3 fields per experimental group
were counted in blinded manner. * Student’s t-test value of p<0.05. **
Student’s t-test value of p<0.01
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Figure 31– PKCδ-cat-Induced P~H3(S10) Positive Cells Have Variable DNA
Content. Primary keratinocytes were retrovirally transduced with
either Linker, or PKCδ-cat-ER. Cells were treated with 10μM 4hydroxytamoxifen on day 1 and collected for staining on day 3. Cells
were stained with anti-P~H3(S10) and propidium iodide for flow
cytometry analysis. A) representative histograms from 3 separate
experiments. B) Error bars denote the standard deviation of the mean
from experiments performed in triplicate. * Student’s t-test value of
p<0.005.
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Figure 32– PKCδ-cat Phosphorylates Histone H3 (S10) in vitro. Recombinant
PKCδ-cat was generated by incubation with recombinant activated
caspase 3. Reactions were then incubated with recombinant histone H3
and ATP. Proteins from the reactions were subjected to Western
blotting to measure the cleavage of PKCδ and phosphorylation of
Histone H3 on Ser10 using anti-P~H3(S10) monoclonal antibody.
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5.2 PKCδ is Required for UV Radiation-Induced Phosphorylation of Histone H3

Since we had determined that PKCδ-cat induced P~H3(S10) in interphase cells, and that
PKCδ could directly phosphorylate histone H3 in vitro, we next addressed the question of
whether PKCδ was required for the phosphorylation of histone H3. Since it has been
previously reported that UV radiation can induce the phosphorylation of histone H3, and
UV radiation is known to activate PKCδ, we decided on a model of UV-induced histone
H3 phosphorylation to test the requirement for PKCδ (He et al., 2005b). As in our cell
cycle studies described in Chapter 4, we utilized WT and PKCδ null MEFs for our PKCδ
loss of function studies with regards to histone H3 phosphorylation.

As expected, UV-irradiation of WT MEFs resulted in elevated levels of P~H3(S10) as
measured both by Western blot, and P~H3(S10) FACS analysis (Figure 31 and 32).
Furthermore, the UV induced phosphorylation occurred in cells across the cell cycle.
Strikingly, PKCδ null MEFs did not demonstrate an increase in phosphorylated histone
H3 after exposure to UV radiation, suggesting that PKCδ is required for this event
(Figure 31 and 32).

Similarly, treatment of HaCaT cells with PKCδ siRNA not only protected the cells from
UV-induced apoptosis, but also resulted in decreased levels of P~H3(S10) before and
after UV radiation, suggesting that the findings in the MEF system can be applied to
human cells (Figure 33). Please note that in this experiment, the cells were not subjected
to growth factor withdrawal, resulting in an elevated level of baseline P~H3(S10) prior to
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UV due to the high percentage of cells within mitosis at the time of the assay. This
results in an apparent decrease in P~H3(S10) levels after UV radiation exposure, and this
decrease can likely be explained by a UV-induced decrease in mitotic index.
5.3 UV Radiation Exposure Induces Nuclear Foci Containing PKCδ/P~H3(S10)

The discovery that, at least in vitro, PKCδ-cat was capable of directly phosphorylating
histone H3(S10) led us to investigate whether any co-localization between PKCδ and
phosphorylated H3 could be detected after exposure of HaCaT cells to UV radiation. To
visualize PKCδ protein, we retrovirally transduced PKCδ-GFP into HaCaT cells. In
control HaCaT cells, PKCδ-GFP was detected in both the cytoplasm and the nucleus,
however, the localization pattern was diffuse in both compartments (Figure 34).
Following exposure to UV, nuclear PKCδ-GFP localization shifted to a much more
punctate pattern. Furthermore, the PKCδ-GFP foci that formed following UV exposure
appeared to co-localize with regions of intense DAPI staining, suggesting that PKCδGFP was recruited to condensed chromatin following UV-irradiation.

We also investigated P~H3(S10) staining patterns before and after cells were exposed to
30 mJ/cm² UV radiation. In control HaCaT cells, significant histone H3 phosphorylation
was only detected in mitotic cell populations, and no noticeable co-localization between
P~H3(S10) and PKCδ-GFP was observed (Figure 35). In contrast, HaCaT cells exposed
to UV radiation had an overall higher level of P~H3(S10). Furthermore, the P~H3(S10)
staining indicated that the phosphorylation of histone H3 was occurring on distinct subnuclear foci, and these foci co-localized with regions that also had elevated levels of
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PKCδ-GFP (Figure 35B). This finding demonstrates that following UV radiation
exposure, PKCδ is in the proper location to phosphorylate histone H3(S10).

We considered the possibility that following UV-irradiation, PKCδ might co-localize
with proteins that have more clearly defined roles in the DNA damage response. By
establishing additional patterns of co-localization, we may be able to develop a better
understanding for the role of histone H3 phosphorylation in the response to UV radiation.
With this in mind, we decided to investigate two well characterized markers of the DNA
repair, Rad9 and γH2AX. Strikingly, both were induced by UV-radiation exposure,
however, in contrast to the P~H3(S10) staining after UV, there appeared to be no obvious
co-localization with PKCδ nuclear foci (Figures 36 and 37).

5.4 Are There Structural Changes to P~H3(S10) Associated Chromatin?

Histone H3 phosphorylation on Ser 10 and 28 is tightly linked to chromatin condensation
during mitosis. It is also well known that many nuclear changes, including chromatin
condensation, occur during mitosis, but the mechanism of apoptotic chromatin
condensation is not well understood. Given the role of histone H3 phosphorylation during
mitosis, we questioned whether there may be an analogous role for this phosphorylation
event during apoptotic chromatin condensation. To study this hypothesis, we generated
chromosome spreads from Linker and PKCδ-cat-ER expressing primary keratinocytes.
We stained these spreads with DAPI and anti-P~H3(S10) to visualize the chromatin
architecture of PKCδ-cat induced P~H3(S10) positive cells. However, despite the fact
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that PKCδ-cat induced P~H3(S10) positive cells lacked mitotic chromosomes, they could
not be distinguished from normal interphase nuclei, suggesting that there were no
detectable gross changes to chromatin structure in these cells (Figure 38). This finding
does not rule out the possibility PKCδ induced P~H3(S10) causes structural changes to
the chromatin, and may simply be a reflection of the limitations of this assay to detect
changes to chromatin architecture.
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Figure 33– PKCδ is Required for the UV-Induced Phosphorylation of Histone
H3(S10). WT and PKCδ Null MEFs were treated with or without
30mJ/cm² UV radiation. Cells were collected 18hrs post-irradiation,
fixed, and stained with anti-P~H3(S10) and propidium iodide. A)
Representative histograms showing UV-induced P~H3(S10) in WT but
not PKCδ null MEFs. B) Error bars denote the standard deviation of
the mean from experiments performed in triplicate. * Student’s t-test
value of p<0.005.
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Figure 34– PKCδ is Required for the UV-Induced Phosphorylation of Histone
H3(S10). WT and PKCδ Null MEFs were grown in DMEM plus 0.1%
FBS to induce G1 growth arrest for 48hrs. Cells were then treated with
or without 30mJ/cm² UV radiation. Protein lysates were collected
18hrs post-irradiation and subjected to Western blot analysis to
measure levels of P~H3(S10)
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Figure 35–Knockdown of PKCδ Suppresses Apoptosis and UV-Induced
Phosphorylation of Histone H3(S10) in HaCaT Cells. HaCaT cells
were transfected with CTRL or PKCδ siRNA. 48 hrs post-transfection,
cells were treated with or without UV. 18 hrs post-UV-irradiation A)
cells were collected for FACS analysis of apoptosis, and B) protein
lysates were gathered and subjected to Western blot analysis of PKCδ
and P~H3(S10) levels.
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Figure 36–UV Induces PKCδ Recruitment to Nuclear Foci. HaCaT cells were
retrovirally transduced to express PKCδ-GFP. Following infection cells
were treated with or without 30 mJ/cm² UV radiation. Cells were fixed
18hrs post irradiation, stained with DAPI to visualize chromatin, and
photographed using a confocal microscope. Images were taken at 40x
magnification.
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Figure 37–UV-Induced Co-localization of PKCδ with P~H3(S10). HaCaT cells
were retrovirally transduced to express PKCδ-GFP. Following
infection cells were treated with or without 30 mJ/cm² UV radiation.
Cells were fixed 18hrs post irradiation, stained with anti-P~H3(S10)
and DAPI and photographed using a confocal microscope. A) 40x
magnification. B) 160x magnification.
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Figure 38A–Control HaCaT-PKCδ-GFP cells display diffuse PKCδ-GFP
nuclear localization, and weak Rad9 staining. HaCaT cells
expressing PKCδ-GFP were plated on coverslips, fixed and stained for
Rad9 and DAPI. Images are displayed at 80x magnification.
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Figure 38B–UV-Induced Rad9 foci do not colocalize with PKCδ-GFP HaCaT
cells expressing PKCδ-GFP were plated on coverslips, exposed to 30
mJ/cm² UV radiation, fixed 18 hrs post UV, and stained for Rad9 and
DAPI. Images are displayed at 80x magnification.
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Figure 39A–Control HaCaT-PKCδ-GFP cells display diffuse PKCδ-GFP
nuclear localization, and weak γH2AX staining. HaCaT cells
expressing PKCδ-GFP were plated on coverslips, fixed and stained for
γH2AX and DAPI. Images are displayed at 80x magnification.
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Figure 39B–UV-induced γH2AX foci do not colocalize with PKCδ-GFP.
HaCaT cells expressing PKCδ-GFP were plated on coverslips, exposed
to 30 mJ/cm² UV radiation, fixed 18 hrs post UV, and stained for
γH2AX and DAPI. Images are displayed at 80x magnification.
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Figure 40–PKCδ-cat-ER Induced P~H3(S10) Positive Nuclei do not show
Obvious Alterations to Chromatin Morphology. Primary
Keratinocytes expressing either Linker or PKCδ-cat-ER were treated
with 4-hydroxytamoxifen, fixed and chromosomal morphology was
analyzed using chromosome spreading technique.
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Chapter 6
Other Findings of Note

6.1 PKCδ is Required for Efficient Repair of UV-Induced Thymine Dimers

It has been previously reported that PKCδ is important for the DNA damage-induced
activation of the DNA repair/cell cycle checkpoint protein Rad9 (Yoshida et al., 2003).
We postulated that if PKCδ is important for the activation of critical components of the
DNA repair machinery, then PKCδ loss may impair the cells ability to repair damaged
DNA. This would be particularly deleterious in the case of the epidermis, since the
exposure to UV radiation from the sun is known to be highly mutagenic. To investigate
the role, if any, of PKCδ in the repair of UV damaged DNA, we exposed WT and PKCδ
null MEFs to 75 mJ/cm² UV radiation. We then used a Southwestern blotting technique
to directly measure thymine dimer levels over time, since thymine dimer formation is a
key step in the mutagenic effects of UV. The successful repair of UV damaged DNA
should correlate with decreased thymine dimer levels. We found that compared to the
WT MEFs, PKCδ null MEFs were impaired in their ability to remove thymine dimers
following UV exposure (Figure 39). This suggests that PKCδ has an important function
in promoting the repair of UV damaged DNA, although whether this role is connected to
the ability of PKCδ to promote cell cycle arrest remains to be determined.
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Figure 41–Delayed Removal of Thymine Dimers in PKCδ Null MEFs. WT and
PKCδ null MEFs were exposed to 75 mJ/cm² UV radiation and DNA
was collected at the indicated timepoints and subjected to Southwestern
blot analysis of thymine dimer levels. A) Thymine dimer southwestern
blot showing thymine dimer levels at indicated time points post-UV
irradiation. B) Densitometric analysis of bands in A shows delayed
removal of thymine dimers in PKCδ null MEFs.
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6.2 PKCδ Suppresses Colony Formation and Anchorage Independent Growth

A common in vitro measure of tumorigenicity is the ability of cells to evade contact
inhibition and form foci after growth to confluency, and the ability of cells to grow in an
anchorage-independent manner (ie. in soft agar or methylcellulose). Since PKCδ can
suppress proliferation by inducing cell cycle arrest, and apoptosis, we sought to
determine whether the loss of PKCδ would enhance these characteristics in PKCδ null
MEFs compared to their WT counterparts. Strikingly, while WT MEFs underwent a
sustained confluency induced growth arrest, PKCδ null MEFs formed numerous foci that
were clearly visible after crystal violet staining (Figure 40). This suggests that the loss of
PKCδ allows MEFs to escape from contact inhibition, allowing them to continue to
proliferate, even when grown under confluent conditions.

When grown in soft agar, WT MEFs formed no detectable colonies. In contrast, PKCδ
null MEFs formed numerous colonies detectable by MTT staining, and the ability to
grow in soft agar could be re-expressed by ectopically expressing PKCδ-GFP (Figure
41). The ability of PKCδ-GFP expression to suppress growth suggests that the ability to
grow in soft agar was a direct consequence of PKCδ loss, and not an artifact of the MEF
immortalization process.
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Figure 42–PKCδ loss allows escape from contact inhibition. WT and PKCδ
null MEFs were maintained under confluent culture conditions for 7
days, fixed, and stained with crystal violet to visualize confluency
induced foci. Note that while WT MEFs appear to have arrested upon
reaching confluency, PKCδ null MEFs have formed numerous colonies
across the plates.
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Figure 43–PKCδ-GFP Suppresses the Growth of PKCδ Null MEFs in Soft
Agar. Control and PKCδ-GFP transduced PKCδ null MEFs were
suspended in soft agar and cultured for 7 days prior to addition of DTT
to label metabolically active cells. A) Representative image of DTT
labeled colonies in Control and PKCδ-GFP transduced PKCδ null
MEFs. B) Colonies in Control and PKCδ-GFP transduced PKCδ null
MEFs per 35mm culture dish were counted.
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Chapter 7
Discussion

7.1 The PKCδ Catalytic Fragment is a Critical Regulator of the G2/M Checkpoint.

The majority of studies on PKCδ function have focused on the pro-apoptotic role that the
kinase plays both in vivo and in vitro. We have now demonstrated that in addition to
these pro-apoptotic effects, PKCδ also regulates cell cycle progression by participating in
the G2/M DNA damage checkpoint. We have shown that retroviral expression of PKCδcat in primary KCs, immortalized KCs with mutant p53, and MEFs is sufficient to induce
G2/M checkpoint activation and cell cycle arrest. PKCδ-cat induced G2/M checkpoint
activation requires kinase competent PKCδ since a kinase dead PKCδ mutant failed to
activate the G2/M checkpoint (Figure 21 and 22).

Based on our studies, PKCδ appears to also play an important role in the response to γradiation (Figure 19). Although PKCδ null MEFs underwent a significant G2/M arrest
following high dose γ-radiation (20 Gy), the arrest was significantly diminished when
compared to the arrest which occurred in the WT MEFs. Furthermore, no detectable
G2/M arrest occurred in the PKCδ null MEFs following exposure to low dose γ-radiation
(4 Gy).

It is well known that the type of DNA damage caused by the ultraviolet and ionizing
radiation are very different, and as a result, different DNA repair pathways are activated
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in response to each. Ionizing radiation induces both single and double stranded breaks in
the DNA, and activates NHEJ or HR DNA repair responses (See Chapter 1.4.4-1.4.6). In
contrast, UV radiation causes the formation of bulky DNA adducts (ie. pyrimidine
dimers), and the nucleotide excision repair pathway is required for the proper removal of
these adducts (1.4.3). Similarly, UV and ionizing radiation activate different upstream
components of cell cycle checkpoint pathways, although many of the mediators of these
pathways are shared. Ionizing radiation activates cell cycle checkpoints through ATM,
and a lesser extent ATR activation. In contrast, UV radiation induces a checkpoint
response primarily through ATR. The use of multiple upstream kinases to respond to
different types of DNA damage likely allows the cell to respond to a wide variety of
genotoxic stresses with the same outcome, that is cell cycle arrest, DNA repair, and if the
damage is of a high enough severity, apoptosis.

The relative requirement for PKCδ to elicit proper checkpoint signaling in response to
UV as compared to γ-radiation, indicates that PKCδ activation likely occurs downstream
of both ATM and ATR mediated checkpoint responses. Interestingly, ATM has been
reported to phosphorylate and activate PKCδ in response to 5-azacytidine treatment
(Yoshida et al., 2003). Whether ATR can similarly activate PKCδ in response to UV
exposure remains to be determined. Regardless of the activation of PKCδ downstream of
ATM or ATR, the diminished G2/M cell cycle arrest after both UV and γ-radiation in
PKCδ null MEFs suggests that PKCδ may be required for the response to a wide variety
of DNA damaging agents, and may even be universally required for maintenance of the
G2/M checkpoint over time. The role for PKCδ in checkpoint maintenance may be
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critical for providing the cell with enough time to properly repair all DNA damage before
resuming cell cycle progression, indicating that PKCδ is critical for preserving genomic
integrity.

7.2 Caspase Cleavage is Critical for PKCδ Induced Checkpoint Function

In addition to kinase activity, the cleavage of PKCδ appears to be critical to checkpoint
integrity since the expression of a caspase-resistant PKCδ(D327A)-GFP mutant was
unable to restore the G2/M checkpoint in PKCδ null MEFs (Figures 21 and 22). PKCδ is
cleavable by numerous proteases including caspases 2 and 3, but the protease responsible
for cleaving PKCδ in this circumstance remains unclear (Denning et al., 1998; Emoto et
al., 1995; Panaretakis et al., 2005). It is possible that PKCδ may be a substrate for the
caspase 2 containing DNA-PKcs-PIDDosome complex which was recently demonstrated
to be integral to proper G2/M checkpoint maintenance after ionizing radiation exposure
(Shi et al., 2009). Indeed, previous work in our lab has demonstrated that both caspase 2
and 3 can cleave PKCδ in vitro (unpublished results from Dr. L. Sitailo). Caspase 2
appears to be unique among the caspases in that it is the only caspase with constitutive
nuclear localization, and appears to play an important role not only in the apoptotic
cascade, but also in regulating cell cycle progression (Shi et al., 2009; Zhivotovsky et al.,
1999; Ho et al., 2009). Further studies will need to be done to verify whether caspase 2
mediates the cleavage of PKCδ in vivo, during UV-induced activation of the G2/M
checkpoint.
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Interestingly, PKCδ appears to be required for G2/M checkpoint maintenance rather than
induction, since a decrease in mitotic index was observed in both wild type and PKCδ
null MEFs 1 hour after UV exposure (Figure 17), but not after 6 hours (Figure 16).
Proteins such as p53, p21 and even the DNA-PKcs-PIDDosome complex have been
similarly implicated in G2/M checkpoint maintenance rather than initial checkpoint
activation (Shi et al., 2009; Bunz et al., 1998). This discrepancy in early compared to late
time points of checkpoint activation likely correlates with the appearance of the PKCδ
catalytic fragment, which will only appear once caspases have become activated. The role
for PKCδ in maintenance may reflect a bimodal activation of the G2/M checkpoint
following UV radiation exposure. Initially, checkpoint activation likely occurs through
PKCδ-independent activation of an ATR/Chk1 signaling axis which results in the
phosphorylation and inhibition of Cdk1. This early PKCδ-independent arrest appears tobe
transient, as the loss of PKCδ allows cells to escape UV-induced G2/M arrest at later
timepoints. Because caspase cleavage of PKCδ is important for G2/M checkpoint
function, it is likely that at these later timepoints, PKCδ is cleaved and can participate in
checkpoint maintenance.

7.3 Potential Interactions of PKCδ with DNA Repair and Cell Cycle Machinery

Several PKCδ substrates involved in the DNA damage response have been identified.
These include both p53 and the p53 family member, p73β (Yoshida et al., 2006a; Liu et
al., 2007; Ren et al., 2002). PKCδ has been demonstrated to phosphorylate and activate
the DNA repair protein Rad9 after exposure to the DNA damaging agent 5-azacytidine in
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an ATM-dependent manner (Yoshida et al., 2003). It is possible ATR, a major kinase
activated by UV radiation, is also capable of activating PKCδ in a similar fashion. Other
components of the DNA damage response that have been identified as PKCδ substrates
include DNA-PKcs and topoisomerase IIα (Bharti et al., 1998; Yoshida et al., 2006b).
Together, these studies reveal the importance of PKCδ in the DNA damage repair
pathway and indicate it may be functioning at several levels. Nuclear localization of
PKCδ is important for DNA damage-induced apoptosis, and may be required during
multiple processes following DNA damage, including checkpoint activation (DeVries et
al., 2002; DeVries-Seimon et al., 2007).

The novel cell cycle regulatory role for PKCδ described in Chapters 3 and 4 has
important implications for the role of this protein as a tumor suppressor. Based on these
results, the loss of PKCδ during tumor development would allow for the cell to progress
through the cell cycle, even in the presence of DNA damage, while at the same time
evading apoptosis. This is illustrated by wild type MEFs being driven into apoptosis by
caffeine-induced G2/M checkpoint override after UV irradiation, while PKCδ null MEFs
do not arrest, nor undergo apoptosis even after treatment with caffeine (Figure 18).
Similar to wild type MEFs, KCs are highly sensitive to caffeine treatment after UV
irradiation (Lu et al., 2008; Heffernan et al., 2009). Thus, KCs lacking PKCδ, such as in
squamous papillomas and carcinomas, are also likely to have this dual defect in the
response to DNA damage, resulting in both reduced cell cycle arrest and reduced
apoptosis (D'Costa and Denning, 2005; Reddig et al., 1999; Aziz et al., 2006).

141
Furthermore, concomitant treatment of LZRS-PKCδ-cat-ER transduced cells with the
ATM/ATR inhibitor caffeine was unable to prevent PKCδ-cat-ER induced G2/M arrest.
This suggests that PKCδ-cat is inducing G2/M checkpoint activation independent of the
ATM/ATR kinases, and may actually function internally to the G2/M checkpoint signal
cascade (Figure 41). Consistent with this, UV induced γH2A.X and P~p53(S15) in PKCδ
null MEFs but did not induce P~Cdk1(Y15) (Figure 22).

It will be important in the future to identify substrates for PKCδ within the G2/M
checkpoint signaling hierarchy. We demonstrated that the misregulation of UV-induced
G2/M checkpoint activation that occurs in the absence of PKCδ cannot be explained by
misregulation of Cdc25A (Figure 24). Possible alternatives to Cdc25A include, but are
not limited to, the other Cdc25 phosphatases, the checkpoint kinases Chk1 and Chk2, and
the Cdk1 kinase Wee1 (Russell and Nurse, 1987; Sancar et al., 2004). The importance of
cell cycle checkpoint function to cancer cells has prompted intensive study of small
molecule inhibitors targeted towards components of the G2/M checkpoint such as
ATM/ATR, Chk1 and 2, as well as the Aurora family for potential use as cancer
therapeutics (Schmidt and Bastians, 2007; Bucher and Britten, 2008; Hose et al., 2009).
Better understanding of how PKCδ participates in this cell cycle checkpoint is important
for developing better cancer treatments in the future.
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Figure 44–PKCδ-cat is Important for G2/M Checkpoint Signaling
Downstream or Independent of ATR Signaling. UV-induced
activation of the G2/M DNA damage checkpoint requires PKCδ
cleavage. The substrates of PKCδ within the checkpoint pathway
remain unclear, but it is likely that they function downstream of ATR
signaling since caffeine could not block PKCδ-cat induced G2/M
arrest.
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7.4 PKCδ-cat Induces Histone H3(S10) Phosphorylation Outside of Mitosis

The discovery that PKCδ-cat expression induced the phosphorylation of histone H3 on
Ser10 outside of mitosis, and independently of Aurora B activity was very surprising
(Figures 25-29). Our findings suggest that this phosphorylation event occurred on a
global scale in an analogous manner to that which occurs during mitosis; however, we
did not detect any obvious changes to the chromatin architecture after PKCδ-cat-ER
induced H3 phosphoryation. In addition to its role in mitotic chromatin condensation,
there is increasing evidence for histone H3 phosphorylation during interphase, where it is
important for the transcription of certain genes (Paulson and Taylor, 1982).

Early evidence of histone H3 phosphorylation outside of mitosis came from the discovery
that phosphorylation of the N-terminal tail of histone H3 rapidly occurred in response to a
number of stimuli, including growth factors, phorbol esters, okadaic acid, and protein
synthesis inhibitors (Mahadevan et al., 1991). Histone H3 phosphorylation was then
identified at transcriptionally active heat shock-induced puffs on polytene chromosomes
of D. melanogaster (Nowak and Corces, 2000). Now, specific H3 kinases have been
identified within various pathways of transcriptional activation. For example, TNFα
stimulation of NF-κB target genes involved the phosphorylation of Ser 10 by IKKα
(Yamamoto et al., 2003). Furthermore, EGFR induced gene transcription of c-jun and cfos was accompanied by MSK1 and 2 dependent phosphorylation of histone H3(S10) at
the promoters of these genes (Duncan et al., 2006; Cheung et al., 2000). Histone H3
phosphorylation has now been implicated in a host of additional transcriptional activation
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pathways and at specific gene promoters, including some signaling pathways that are
dependent upon PKC signaling (Lefebvre et al., 2002; DeManno et al., 1999; Huang et
al., 2004; Karrasch et al., 2006).

It remains unclear whether H3 phosphorylation is directly important for transcriptional
activation, or whether it functions as a precursor to other post-translational modifications.
For example, there is a correlation between histone H3 phosphorylation and acetylation
status on the promoters of some genes (Clayton et al., 2000). Indeed the phosphorylation
of histone H3 has been implicated in the recruitment of the histone acetyltransferase
GCN5 (Lo et al., 2000; Espinos et al., 1999; Clements et al., 2003). Other findings,
however, implicate H3(S10) phosphorylation as preventing H3(K9) acetylation
(Edmondson et al., 2002). It should be noted that this finding may be an artifact of the
S10 phosphate shielding the lysine 9 acetylation mark from detection using the lysine 9
acetylated antibody.

How histone H3 phosphorylation can lead to opposing chromatin states, that is open
during trans-activation, and condensed during mitosis, remains a matter of debate. It is
possible that the mark itself does not confer a certain status upon chromatin, but recruits
other proteins and co-factors that mediate the outcome. These mediators may be
regulated in a cell cycle dependent manner, explaining why condensation is the outcome
of H3 phosphorylation during mitosis. It is also possible that the difference arises from
the pattern of phosphorylation. During mitosis, histone H3 is phosphorylated across
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entire chromosomes. In contrast, during gene activation, H3 phosphorylation is present
on specific gene promoters.

UV exposure is known to induce the phosphorylation of histone H3 on Ser10, but the
biological consequence of this phosphorylation event in the context of the response to
UV is not well understood (Allison and Milner, 2003; Zhong et al., 2000). Of note, one
group has described the phosphorylation of histone H3 on Ser 10 during gleotoxin
induced apoptosis, and a correlation between P~H3(S10) and enhanced sensitivity to
nuclease digestion of the chromatin was reported (Waring et al., 1997). Indeed, we found
that UV induced the phosphorylation in WT but not PKCδ null MEFs, suggesting a
requirement for PKCδ in this event (Figures 31-32). Furthermore, PKCδ co-localizes
with P~H3(S10) in the nuclei of UV-irradiated HaCaT cells, raising the possibility that
PKCδ may be the kinase responsible for H3 phosphorylation in response to UV radiation
(Figure 35).

Other histone phosphorylation events have also been implicated in apoptosis. Apoptotic
stimuli induce the phosphorylation of histone H2B on T14, and this phosphorylation has
been implicated in apoptotic chromatin condensation and fragmentation (Ajiro, 2000; Ura
et al., 2007). Since the phosphorylation of H2B and H3 occur during biologically similar
circumstances, it is appealing to speculate that histone H3(S10) phosphorylation may also
be involved in apoptotic chromatin condensation. The kinases implicated in H2B(T14)
phosphorylation during mitosis include Mst1 and particularly interesting in light of these
studies, PKCδ (Cheung et al., 2003; Hu et al., 2007). Interestingly, phosphorylated
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histone H2B co-localizes with γH2AX and components of the DNA damage machinery
during death receptor induced apoptosis, putting it in the proper context to interact with
components of the cell cycle and DNA repair apparatus (Solier and Pommier, 2009;
Solier et al., 2009). PKCδ has also been implicated in the phosphorylation of histone H3
on Thr45 during differentiation induced apoptosis in neutrophils, although it was not
formally proven that this phosphorylation event played a causative role in the cell death
(Hurd et al., 2009).

Additional studies are clearly needed to better understand the biological context of UVinduced phosphorylation of histone H3. That is, when histone H3 becomes
phosphorylated in the response to UV radiation, what is the status of the cell? We are
currently undertaking studies using inhibitors of DNA repair (caffeine), and late stage
apoptosis (z-VAD.fmk) to attempt to block the UV-induced phosphorylation of histone
H3 in WT MEFs. In doing so, we hope to gain a better understanding of when histone H3
becomes phosphorylated in the UV response, as well as what role it may be playing in
said response. Unfortunately, the abundant nature of histone proteins in the cell does not
lend itself to genetic manipulation, and so we are limited to correlations at this point,
barring the extension of these studies into budding yeast, which only have one histone H3
genetic locus.
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Figure 45–UV-Induced Apoptosis Requires PKCδ Cleavage. Apoptotic doses
of UV radiation initiate a cascade of events that converge upon the
cleavage of PKCδ by caspases. Cleaved PKCδ then phosphorylates a
number of targets, which we now believe includes histone H3 to
promote apoptosis. The requirement and consequence of histone H3
phosphorylation remains unclear.
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7.5 Tumor Suppressor Mechanisms of PKCδ

Given the well characterized role of PKCδ in promoting apoptosis, it is not entirely
surprising that most attention on PKCδ as a tumor suppressor has focused on its role in
the apoptotic cascade (Reyland et al., 1999; Reyland et al., 2000; Matassa et al., 2001;
Carpenter et al., 2002; Denning et al., 2002; Lasfer et al., 2006). While the ability to
induce apoptosis is a common characteristic of tumor suppressors, many tumor
suppressors also function by limiting cell cycle progression. PKCδ has been previously
implicated in regulating the progression through multiple stages of the cell cycle,
including G1/S, and mitosis (Lagory et al., 2009; Watanabe et al., 1992; Takahashi et al.,
2006; Ashton et al., 1999; Afrasiabi et al., 2008; Nakagawa et al., 2005).

We believe that in addition to promoting apoptosis, the expanding role of PKCδ in
promoting cell cycle arrest, particularly through the G2/M phase of the cell cycle, may
represent an additional mechanism of PKCδ mediated tumor suppression. The dual
function of PKCδ in both the promotion of apoptosis and cell cycle arrest implies that the
loss of PKCδ expression during tumorigenesis would be especially deleterious. Many, if
not all cancers demonstrate elevated levels of genomic instability. Despite the increased
risk of cancer progression associated with genomic instability, it is inherently toxic to the
cell and can promote both apoptosis and cell cycle arrest. A cell that has lost PKCδ
expression, however, would be naturally resistant to both apoptosis and cell cycle arrest,
allowing the cell to continue to proliferate, accumulating more mutations, and ultimately
allowing the cancer to become more aggressive. The loss of PKCδ would also have
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important implications early during tumorigenesis, as the inability to execute cell cycle
arrest or apoptosis may increase the likelihood that initiating mutations to genes like p53
would be allowed to escape repair.

It will be critical to determine how PKCδ-cat influences G2/M checkpoint activation in
the future, as a better understanding of this checkpoint may uncover novel targets for
cancer therapy. By better understanding the downstream targets of PKCδ-cat, it may be
possible to devise therapeutic strategies to activate important downstream components
even in the absence of PKCδ, a possibility that may be particularly effective in those
tumors which have lost PKCδ expression.
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